Gene Symbol | Gene ID | Gene Info |
---|---|---|
Mybl1
|
ENSMUSG00000025912.10 | myeloblastosis oncogene-like 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr1_9700283_9700834 | Mybl1 | 349 | 0.852645 | 0.55 | 1.5e-05 | Click! |
chr1_9700945_9701173 | Mybl1 | 850 | 0.558584 | 0.22 | 1.1e-01 | Click! |
chr1_9699839_9700254 | Mybl1 | 22 | 0.972528 | 0.14 | 3.1e-01 | Click! |
chr1_9704913_9705064 | Mybl1 | 4779 | 0.175340 | 0.09 | 5.1e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr10_127508848_127510720 | 21.86 |
Stac3 |
SH3 and cysteine rich domain 3 |
2559 |
0.15 |
chr5_8894851_8895125 | 20.80 |
Abcb4 |
ATP-binding cassette, sub-family B (MDR/TAP), member 4 |
1039 |
0.47 |
chr10_59800856_59801208 | 18.61 |
Gm17059 |
predicted gene 17059 |
778 |
0.56 |
chr15_98606348_98606519 | 15.89 |
Adcy6 |
adenylate cyclase 6 |
1200 |
0.28 |
chr2_181463028_181463619 | 15.75 |
Zbtb46 |
zinc finger and BTB domain containing 46 |
3897 |
0.13 |
chr16_49800061_49800448 | 14.47 |
Cd47 |
CD47 antigen (Rh-related antigen, integrin-associated signal transducer) |
279 |
0.89 |
chr6_5155896_5156279 | 14.44 |
Pon1 |
paraoxonase 1 |
37676 |
0.14 |
chr3_51340298_51341882 | 14.43 |
Elf2 |
E74-like factor 2 |
427 |
0.74 |
chr15_79690079_79691459 | 14.21 |
Gtpbp1 |
GTP binding protein 1 |
76 |
0.92 |
chr10_80857950_80858283 | 14.12 |
Sppl2b |
signal peptide peptidase like 2B |
995 |
0.29 |
chr17_35164786_35165560 | 13.98 |
Gm17705 |
predicted gene, 17705 |
54 |
0.72 |
chr5_140034121_140034770 | 13.32 |
Gm43702 |
predicted gene 43702 |
2269 |
0.28 |
chr16_30453325_30453494 | 13.12 |
Gm49679 |
predicted gene, 49679 |
821 |
0.66 |
chr1_194815643_194816066 | 13.04 |
Gm19777 |
predicted gene, 19777 |
4233 |
0.18 |
chr1_77298959_77299132 | 13.01 |
Epha4 |
Eph receptor A4 |
78562 |
0.11 |
chr19_4558622_4558983 | 12.73 |
Pcx |
pyruvate carboxylase |
8 |
0.97 |
chr7_103870533_103870999 | 12.06 |
Olfr66 |
olfactory receptor 66 |
11475 |
0.06 |
chr13_24419481_24419859 | 11.94 |
Cmah |
cytidine monophospho-N-acetylneuraminic acid hydroxylase |
2446 |
0.22 |
chr4_119190676_119190850 | 11.79 |
Ermap |
erythroblast membrane-associated protein |
752 |
0.43 |
chr5_44203445_44203962 | 11.78 |
Tapt1 |
transmembrane anterior posterior transformation 1 |
640 |
0.58 |
chr4_135494313_135495270 | 11.46 |
Stpg1 |
sperm tail PG rich repeat containing 1 |
1 |
0.68 |
chr14_75178362_75178525 | 11.26 |
Lcp1 |
lymphocyte cytosolic protein 1 |
2235 |
0.25 |
chr6_83395962_83396123 | 11.23 |
Mir6374 |
microRNA 6374 |
5060 |
0.13 |
chr17_17625011_17625618 | 11.17 |
Lnpep |
leucyl/cystinyl aminopeptidase |
264 |
0.9 |
chr18_61505484_61505773 | 11.05 |
Arhgef37 |
Rho guanine nucleotide exchange factor (GEF) 37 |
3651 |
0.16 |
chr3_103914017_103915242 | 10.83 |
Rsbn1 |
rosbin, round spermatid basic protein 1 |
62 |
0.95 |
chr3_121474804_121475157 | 10.72 |
Slc44a3 |
solute carrier family 44, member 3 |
14069 |
0.15 |
chr17_84116334_84117105 | 10.68 |
Gm19696 |
predicted gene, 19696 |
19241 |
0.15 |
chr19_53887073_53887383 | 10.66 |
Gm50272 |
predicted gene, 50272 |
3861 |
0.18 |
chr5_134919387_134919570 | 10.61 |
4933439J24Rik |
RIKEN cDNA 4933439J24 gene |
310 |
0.68 |
chr5_134919074_134919381 | 10.51 |
4933439J24Rik |
RIKEN cDNA 4933439J24 gene |
561 |
0.47 |
chr13_112746381_112746563 | 10.46 |
Slc38a9 |
solute carrier family 38, member 9 |
10862 |
0.15 |
chr18_36440342_36440531 | 10.38 |
Pfdn1 |
prefoldin 1 |
10808 |
0.18 |
chr2_155989219_155989379 | 10.35 |
Cep250 |
centrosomal protein 250 |
3384 |
0.13 |
chr15_98602185_98602446 | 10.34 |
Adcy6 |
adenylate cyclase 6 |
2416 |
0.14 |
chr18_67573555_67573723 | 10.21 |
Gm17669 |
predicted gene, 17669 |
11245 |
0.17 |
chr2_127371583_127371781 | 10.21 |
Adra2b |
adrenergic receptor, alpha 2b |
8396 |
0.14 |
chr19_58979054_58979221 | 10.08 |
Eno4 |
enolase 4 |
23681 |
0.16 |
chr15_36338833_36339076 | 9.93 |
Gm33936 |
predicted gene, 33936 |
10800 |
0.13 |
chr13_101545903_101546217 | 9.89 |
Gm47533 |
predicted gene, 47533 |
854 |
0.53 |
chr17_33899741_33899912 | 9.79 |
Smim40 |
small integral membrane protein 40 |
5309 |
0.05 |
chr3_100439191_100439416 | 9.78 |
Gm43121 |
predicted gene 43121 |
1469 |
0.34 |
chr12_82225804_82226178 | 9.78 |
Sipa1l1 |
signal-induced proliferation-associated 1 like 1 |
30594 |
0.19 |
chr11_107469708_107471023 | 9.76 |
Pitpnc1 |
phosphatidylinositol transfer protein, cytoplasmic 1 |
334 |
0.82 |
chr13_112024736_112025023 | 9.74 |
Gm15323 |
predicted gene 15323 |
19377 |
0.18 |
chr6_88915651_88916398 | 9.73 |
Gm44178 |
predicted gene, 44178 |
3684 |
0.14 |
chr9_66916250_66916812 | 9.71 |
Rab8b |
RAB8B, member RAS oncogene family |
3156 |
0.21 |
chr18_56977792_56978080 | 9.69 |
C330018D20Rik |
RIKEN cDNA C330018D20 gene |
2568 |
0.32 |
chrX_169997850_169998483 | 9.65 |
Gm15247 |
predicted gene 15247 |
11227 |
0.14 |
chr14_21074009_21074288 | 9.60 |
Adk |
adenosine kinase |
2004 |
0.35 |
chr5_123076757_123077212 | 9.58 |
Tmem120b |
transmembrane protein 120B |
614 |
0.54 |
chr17_25943201_25943527 | 9.58 |
Pigq |
phosphatidylinositol glycan anchor biosynthesis, class Q |
502 |
0.51 |
chr16_49777090_49777249 | 9.51 |
Gm15518 |
predicted gene 15518 |
21701 |
0.2 |
chr4_98190095_98190255 | 9.46 |
Gm12691 |
predicted gene 12691 |
39914 |
0.15 |
chr13_104037534_104037876 | 9.43 |
Nln |
neurolysin (metallopeptidase M3 family) |
63 |
0.98 |
chr1_90289239_90289505 | 9.40 |
Gm28723 |
predicted gene 28723 |
8914 |
0.18 |
chr2_173032812_173033942 | 9.30 |
Gm14453 |
predicted gene 14453 |
1203 |
0.38 |
chr11_87726236_87726559 | 9.30 |
Rnf43 |
ring finger protein 43 |
1029 |
0.34 |
chr19_53941166_53941437 | 9.30 |
Bbip1 |
BBSome interacting protein 1 |
2879 |
0.18 |
chr18_42510920_42511513 | 9.25 |
Tcerg1 |
transcription elongation regulator 1 (CA150) |
271 |
0.91 |
chr3_9662996_9663320 | 9.21 |
Gm17806 |
predicted gene, 17806 |
6638 |
0.22 |
chr11_95356559_95356764 | 9.17 |
Fam117a |
family with sequence similarity 117, member A |
16699 |
0.11 |
chr5_103737363_103737552 | 9.17 |
Aff1 |
AF4/FMR2 family, member 1 |
16705 |
0.19 |
chr14_75837044_75838069 | 9.16 |
Gm48931 |
predicted gene, 48931 |
3930 |
0.16 |
chr19_55273417_55273586 | 9.15 |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
631 |
0.71 |
chr10_94072970_94073143 | 9.11 |
Fgd6 |
FYVE, RhoGEF and PH domain containing 6 |
514 |
0.71 |
chr3_152114756_152115116 | 9.09 |
Gipc2 |
GIPC PDZ domain containing family, member 2 |
6414 |
0.15 |
chr2_27981631_27981939 | 9.07 |
Col5a1 |
collagen, type V, alpha 1 |
35656 |
0.15 |
chr6_73232363_73232587 | 9.07 |
Gm40377 |
predicted gene, 40377 |
9425 |
0.17 |
chr17_4380955_4381265 | 9.00 |
4930517M08Rik |
RIKEN cDNA 4930517M08 gene |
253868 |
0.02 |
chr13_99754247_99754560 | 8.99 |
Gm24471 |
predicted gene, 24471 |
61874 |
0.12 |
chr12_84204018_84204228 | 8.98 |
Gm31513 |
predicted gene, 31513 |
8154 |
0.11 |
chr12_12428967_12429271 | 8.87 |
4921511I17Rik |
RIKEN cDNA 4921511I17 gene |
36504 |
0.21 |
chr8_34097215_34097650 | 8.87 |
Dctn6 |
dynactin 6 |
259 |
0.86 |
chr11_32296147_32296690 | 8.86 |
Hba-a2 |
hemoglobin alpha, adult chain 2 |
71 |
0.95 |
chr18_84885392_84885727 | 8.83 |
Cyb5a |
cytochrome b5 type A (microsomal) |
7958 |
0.17 |
chr9_63757305_63758776 | 8.79 |
Smad3 |
SMAD family member 3 |
46 |
0.98 |
chr8_122286979_122287274 | 8.73 |
Zfpm1 |
zinc finger protein, multitype 1 |
4985 |
0.17 |
chr6_148603015_148603196 | 8.73 |
Gm6313 |
predicted gene 6313 |
6628 |
0.21 |
chr5_36721137_36721299 | 8.70 |
D5Ertd579e |
DNA segment, Chr 5, ERATO Doi 579, expressed |
25194 |
0.11 |
chr6_67186949_67187125 | 8.63 |
Gm8566 |
predicted pseudogene 8566 |
18582 |
0.12 |
chr10_12962337_12962498 | 8.56 |
Stx11 |
syntaxin 11 |
1841 |
0.35 |
chr6_41703997_41704189 | 8.55 |
Kel |
Kell blood group |
246 |
0.88 |
chr16_36891556_36891720 | 8.53 |
Gm49600 |
predicted gene, 49600 |
2756 |
0.14 |
chr2_103957767_103958059 | 8.53 |
Lmo2 |
LIM domain only 2 |
73 |
0.96 |
chr1_136361046_136361197 | 8.53 |
Camsap2 |
calmodulin regulated spectrin-associated protein family, member 2 |
15017 |
0.15 |
chr18_68227583_68228114 | 8.52 |
Ldlrad4 |
low density lipoprotein receptor class A domain containing 4 |
219 |
0.94 |
chr6_86130065_86130447 | 8.49 |
Gm19596 |
predicted gene, 19596 |
16896 |
0.14 |
chr2_102365058_102365209 | 8.49 |
Trim44 |
tripartite motif-containing 44 |
35124 |
0.17 |
chr10_21196984_21197164 | 8.48 |
Gm40608 |
predicted gene, 40608 |
7892 |
0.15 |
chrY_90771840_90772811 | 8.48 |
Gm47283 |
predicted gene, 47283 |
12413 |
0.17 |
chr10_5206032_5206327 | 8.44 |
Syne1 |
spectrin repeat containing, nuclear envelope 1 |
11472 |
0.28 |
chr16_97953407_97953575 | 8.43 |
Zbtb21 |
zinc finger and BTB domain containing 21 |
393 |
0.84 |
chr1_191855059_191855511 | 8.43 |
Nek2 |
NIMA (never in mitosis gene a)-related expressed kinase 2 |
28137 |
0.12 |
chr12_53832616_53832787 | 8.43 |
1700060O08Rik |
RIKEN cDNA 1700060O08 gene |
246691 |
0.02 |
chr1_23282324_23282489 | 8.41 |
Gm27028 |
predicted gene, 27028 |
9131 |
0.12 |
chr11_115902233_115902570 | 8.40 |
Smim5 |
small integral membrane protein 5 |
2199 |
0.15 |
chr7_142568972_142569582 | 8.37 |
H19 |
H19, imprinted maternally expressed transcript |
7261 |
0.1 |
chr2_155604966_155605247 | 8.37 |
Myh7b |
myosin, heavy chain 7B, cardiac muscle, beta |
6106 |
0.08 |
chr7_128854217_128854571 | 8.28 |
Gm25778 |
predicted gene, 25778 |
28047 |
0.15 |
chr13_75733796_75734110 | 8.27 |
Gm48302 |
predicted gene, 48302 |
6674 |
0.14 |
chr4_148204076_148204384 | 8.27 |
Fbxo2 |
F-box protein 2 |
43609 |
0.08 |
chr6_125565069_125565345 | 8.25 |
Vwf |
Von Willebrand factor |
1044 |
0.56 |
chr15_9463851_9464040 | 8.24 |
Gm50456 |
predicted gene, 50456 |
11557 |
0.2 |
chr17_36869921_36870137 | 8.19 |
Trim10 |
tripartite motif-containing 10 |
455 |
0.63 |
chr19_44394817_44395182 | 8.16 |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
11691 |
0.14 |
chr2_153560652_153561518 | 8.15 |
Nol4l |
nucleolar protein 4-like |
31114 |
0.15 |
chr5_147441974_147442285 | 8.13 |
Gm42883 |
predicted gene 42883 |
2739 |
0.14 |
chr6_57767219_57767399 | 8.12 |
Vopp1 |
vesicular, overexpressed in cancer, prosurvival protein 1 |
57331 |
0.07 |
chr15_100738414_100738782 | 8.10 |
I730030J21Rik |
RIKEN cDNA I730030J21 gene |
5861 |
0.13 |
chr2_49730225_49730511 | 8.10 |
Kif5c |
kinesin family member 5C |
2243 |
0.36 |
chr1_75136418_75136604 | 8.10 |
Cnppd1 |
cyclin Pas1/PHO80 domain containing 1 |
1295 |
0.23 |
chr8_94178954_94179363 | 8.02 |
Mt1 |
metallothionein 1 |
53 |
0.95 |
chrX_143011915_143012211 | 8.00 |
Ammecr1 |
Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1 |
45335 |
0.15 |
chr11_90727180_90727365 | 7.97 |
Tom1l1 |
target of myb1-like 1 (chicken) |
38906 |
0.15 |
chr5_23921352_23921515 | 7.96 |
Fam126a |
family with sequence similarity 126, member A |
1471 |
0.33 |
chr11_98904631_98904915 | 7.96 |
Cdc6 |
cell division cycle 6 |
3028 |
0.15 |
chr18_63708478_63709360 | 7.96 |
Txnl1 |
thioredoxin-like 1 |
118 |
0.62 |
chr5_129974852_129975023 | 7.95 |
Vkorc1l1 |
vitamin K epoxide reductase complex, subunit 1-like 1 |
2057 |
0.19 |
chr11_64930815_64930992 | 7.91 |
Elac2 |
elaC ribonuclease Z 2 |
48135 |
0.15 |
chr19_40813987_40814138 | 7.89 |
Ccnj |
cyclin J |
17217 |
0.16 |
chr16_4896345_4896511 | 7.88 |
Mgrn1 |
mahogunin, ring finger 1 |
10042 |
0.11 |
chr10_41204721_41204894 | 7.87 |
Gm25526 |
predicted gene, 25526 |
11238 |
0.2 |
chr11_29815389_29815572 | 7.87 |
Eml6 |
echinoderm microtubule associated protein like 6 |
6182 |
0.16 |
chr19_32237388_32237555 | 7.82 |
Sgms1 |
sphingomyelin synthase 1 |
1341 |
0.5 |
chr7_100500401_100501097 | 7.81 |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
2403 |
0.14 |
chr12_111443494_111443821 | 7.81 |
Tnfaip2 |
tumor necrosis factor, alpha-induced protein 2 |
667 |
0.58 |
chr15_78923627_78923929 | 7.79 |
Lgals1 |
lectin, galactose binding, soluble 1 |
2947 |
0.1 |
chr9_90233420_90233612 | 7.78 |
Gm16200 |
predicted gene 16200 |
11891 |
0.16 |
chr14_70107012_70107367 | 7.72 |
Bin3 |
bridging integrator 3 |
7024 |
0.15 |
chr18_67436617_67436802 | 7.71 |
Afg3l2 |
AFG3-like AAA ATPase 2 |
761 |
0.59 |
chr2_153221743_153221912 | 7.70 |
Tspyl3 |
TSPY-like 3 |
3614 |
0.16 |
chr6_72109561_72109904 | 7.68 |
St3gal5 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 5 |
5500 |
0.13 |
chr6_7698045_7698383 | 7.68 |
Asns |
asparagine synthetase |
4960 |
0.24 |
chr15_97785832_97786003 | 7.68 |
Slc48a1 |
solute carrier family 48 (heme transporter), member 1 |
1428 |
0.3 |
chr2_28602586_28602791 | 7.67 |
Gm22824 |
predicted gene, 22824 |
5507 |
0.11 |
chr17_12204944_12205677 | 7.66 |
Agpat4 |
1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta) |
9815 |
0.17 |
chr2_118659301_118659477 | 7.65 |
Pak6 |
p21 (RAC1) activated kinase 6 |
3914 |
0.18 |
chr12_24875996_24876307 | 7.65 |
Mboat2 |
membrane bound O-acyltransferase domain containing 2 |
44520 |
0.11 |
chr10_62215106_62215283 | 7.65 |
Tspan15 |
tetraspanin 15 |
13417 |
0.15 |
chr11_74837693_74838808 | 7.62 |
Mnt |
max binding protein |
782 |
0.52 |
chr8_122309305_122309664 | 7.60 |
Zfpm1 |
zinc finger protein, multitype 1 |
2164 |
0.24 |
chr17_70850487_70852089 | 7.59 |
Tgif1 |
TGFB-induced factor homeobox 1 |
81 |
0.94 |
chr12_78911724_78912055 | 7.58 |
Plek2 |
pleckstrin 2 |
4925 |
0.2 |
chr5_23924288_23924460 | 7.57 |
Fam126a |
family with sequence similarity 126, member A |
1470 |
0.34 |
chr5_103491085_103491245 | 7.56 |
Ptpn13 |
protein tyrosine phosphatase, non-receptor type 13 |
38401 |
0.14 |
chr4_83623239_83623556 | 7.56 |
Gm27046 |
predicted gene, 27046 |
26094 |
0.17 |
chr13_45849676_45849988 | 7.55 |
Atxn1 |
ataxin 1 |
22456 |
0.23 |
chr10_40149754_40150093 | 7.52 |
Slc16a10 |
solute carrier family 16 (monocarboxylic acid transporters), member 10 |
7665 |
0.13 |
chr18_67670424_67670597 | 7.51 |
Ptpn2 |
protein tyrosine phosphatase, non-receptor type 2 |
19714 |
0.14 |
chr17_50070230_50070402 | 7.50 |
Rftn1 |
raftlin lipid raft linker 1 |
24016 |
0.18 |
chr15_78572662_78572921 | 7.46 |
Rac2 |
Rac family small GTPase 2 |
8 |
0.96 |
chr9_48340771_48341057 | 7.45 |
Nxpe2 |
neurexophilin and PC-esterase domain family, member 2 |
16 |
0.98 |
chr1_82373706_82374341 | 7.43 |
Gm19552 |
predicted gene, 19552 |
21806 |
0.14 |
chr8_120486990_120488549 | 7.41 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
678 |
0.64 |
chr2_28064287_28064444 | 7.41 |
Fcnb |
ficolin B |
20520 |
0.14 |
chr11_87755415_87755594 | 7.40 |
Mir142hg |
Mir142 host gene (non-protein coding) |
73 |
0.91 |
chr4_59234561_59234731 | 7.39 |
Ugcg |
UDP-glucose ceramide glucosyltransferase |
21990 |
0.16 |
chr2_90503274_90503452 | 7.39 |
4933423P22Rik |
RIKEN cDNA 4933423P22 gene |
24113 |
0.16 |
chr4_8689860_8690380 | 7.38 |
Chd7 |
chromodomain helicase DNA binding protein 7 |
286 |
0.93 |
chr4_82815311_82815597 | 7.38 |
Zdhhc21 |
zinc finger, DHHC domain containing 21 |
35360 |
0.17 |
chr13_47111196_47111529 | 7.37 |
1700026N04Rik |
RIKEN cDNA 1700026N04 gene |
4943 |
0.13 |
chr5_73191818_73192155 | 7.36 |
Fryl |
FRY like transcription coactivator |
107 |
0.94 |
chr5_149137596_149137747 | 7.36 |
Gm42788 |
predicted gene 42788 |
6592 |
0.1 |
chr9_121426081_121426568 | 7.36 |
Trak1 |
trafficking protein, kinesin binding 1 |
10349 |
0.19 |
chr1_86161188_86161356 | 7.35 |
Armc9 |
armadillo repeat containing 9 |
6453 |
0.14 |
chr6_134703019_134703308 | 7.33 |
Borcs5 |
BLOC-1 related complex subunit 5 |
1613 |
0.3 |
chr14_74672532_74672729 | 7.32 |
Htr2a |
5-hydroxytryptamine (serotonin) receptor 2A |
31790 |
0.17 |
chr16_32449795_32449957 | 7.31 |
2210020O09Rik |
RIKEN cDNA 2210020O09 gene |
6273 |
0.12 |
chr2_33842970_33843153 | 7.29 |
Nron |
non-protein coding RNA, repressor of NFAT |
37202 |
0.15 |
chr2_32085182_32085571 | 7.28 |
Fam78a |
family with sequence similarity 78, member A |
519 |
0.66 |
chr1_174172656_174172830 | 7.27 |
Spta1 |
spectrin alpha, erythrocytic 1 |
33 |
0.95 |
chr5_146250345_146250644 | 7.26 |
Gm15739 |
predicted gene 15739 |
1943 |
0.23 |
chr6_38342105_38342326 | 7.24 |
Zc3hav1 |
zinc finger CCCH type, antiviral 1 |
12058 |
0.13 |
chr8_13122974_13123380 | 7.24 |
Cul4a |
cullin 4A |
348 |
0.77 |
chr5_53636937_53637100 | 7.23 |
Rbpj |
recombination signal binding protein for immunoglobulin kappa J region |
1614 |
0.46 |
chr7_19693317_19693822 | 7.22 |
Apoc1 |
apolipoprotein C-I |
909 |
0.31 |
chr2_30893330_30893679 | 7.21 |
Ptges |
prostaglandin E synthase |
3965 |
0.16 |
chr8_104250693_104251440 | 7.17 |
Cklf |
chemokine-like factor |
122 |
0.92 |
chr17_87276537_87277114 | 7.17 |
4833418N02Rik |
RIKEN cDNA 4833418N02 gene |
4868 |
0.16 |
chr13_24419060_24419211 | 7.16 |
Cmah |
cytidine monophospho-N-acetylneuraminic acid hydroxylase |
1911 |
0.26 |
chr1_181323221_181323527 | 7.16 |
Cnih3 |
cornichon family AMPA receptor auxiliary protein 3 |
29254 |
0.13 |
chr4_53432052_53432206 | 7.16 |
Slc44a1 |
solute carrier family 44, member 1 |
8284 |
0.22 |
chr6_71801406_71801678 | 7.16 |
Gm44770 |
predicted gene 44770 |
1346 |
0.3 |
chr8_123992737_123992889 | 7.13 |
Abcb10 |
ATP-binding cassette, sub-family B (MDR/TAP), member 10 |
9691 |
0.1 |
chr2_160603665_160603828 | 7.12 |
Gm14221 |
predicted gene 14221 |
16225 |
0.16 |
chr18_68198288_68198478 | 7.11 |
Gm18149 |
predicted gene, 18149 |
29416 |
0.15 |
chr1_170622997_170623376 | 7.10 |
Gm7299 |
predicted gene 7299 |
7735 |
0.19 |
chr4_106296746_106297070 | 7.09 |
Gm37253 |
predicted gene, 37253 |
2515 |
0.22 |
chr5_134915452_134915620 | 7.08 |
Cldn13 |
claudin 13 |
10 |
0.94 |
chr13_14033794_14033945 | 7.08 |
Tbce |
tubulin-specific chaperone E |
5710 |
0.13 |
chr14_51130449_51130628 | 7.07 |
Rnase6 |
ribonuclease, RNase A family, 6 |
1457 |
0.21 |
chr15_91252133_91252292 | 7.06 |
CN725425 |
cDNA sequence CN725425 |
20634 |
0.22 |
chr15_95906315_95906762 | 7.04 |
Gm25070 |
predicted gene, 25070 |
26721 |
0.15 |
chr2_90559777_90559938 | 7.03 |
Ptprj |
protein tyrosine phosphatase, receptor type, J |
20790 |
0.19 |
chr11_96926664_96926823 | 7.02 |
Prr15l |
proline rich 15-like |
1361 |
0.23 |
chr15_35490089_35490249 | 7.00 |
Gm24771 |
predicted gene, 24771 |
2769 |
0.32 |
chr11_117204633_117204995 | 6.99 |
Septin9 |
septin 9 |
5153 |
0.19 |
chr11_109550077_109550245 | 6.98 |
Arsg |
arylsulfatase G |
6407 |
0.18 |
chr16_58514593_58514905 | 6.97 |
St3gal6 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 6 |
565 |
0.76 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.8 | 27.2 | GO:0008228 | opsonization(GO:0008228) |
5.2 | 15.6 | GO:0045472 | response to ether(GO:0045472) |
4.2 | 12.7 | GO:0070836 | caveola assembly(GO:0070836) |
4.0 | 20.0 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
4.0 | 7.9 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
3.9 | 3.9 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
3.9 | 11.7 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
3.8 | 11.4 | GO:0090202 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
3.8 | 11.3 | GO:0036394 | amylase secretion(GO:0036394) |
3.7 | 11.2 | GO:0050904 | diapedesis(GO:0050904) |
3.5 | 10.6 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
3.5 | 14.0 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
3.4 | 10.3 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
3.3 | 10.0 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
3.2 | 9.7 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
3.2 | 12.9 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
3.1 | 9.4 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
3.1 | 6.2 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
3.0 | 12.1 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
3.0 | 11.9 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
2.9 | 8.7 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
2.9 | 14.5 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
2.8 | 8.4 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
2.7 | 13.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
2.7 | 5.4 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
2.6 | 7.9 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
2.6 | 7.9 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
2.6 | 7.8 | GO:0021553 | olfactory nerve development(GO:0021553) |
2.6 | 13.0 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
2.6 | 5.2 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
2.5 | 5.1 | GO:0035754 | B cell chemotaxis(GO:0035754) |
2.5 | 7.6 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
2.5 | 7.4 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
2.5 | 12.3 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
2.4 | 9.8 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
2.4 | 4.8 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
2.3 | 2.3 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
2.3 | 11.5 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
2.3 | 6.9 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
2.3 | 4.5 | GO:0023021 | termination of signal transduction(GO:0023021) |
2.3 | 9.0 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
2.2 | 8.9 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
2.2 | 6.6 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
2.2 | 6.6 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
2.2 | 6.5 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
2.2 | 8.7 | GO:0032264 | IMP salvage(GO:0032264) |
2.2 | 54.0 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
2.1 | 17.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
2.1 | 8.5 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
2.1 | 8.5 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
2.1 | 6.4 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
2.1 | 12.5 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
2.1 | 10.4 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
2.1 | 14.5 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
2.0 | 10.2 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
2.0 | 6.0 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
2.0 | 5.9 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
2.0 | 9.9 | GO:0002155 | regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
2.0 | 7.9 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
2.0 | 7.8 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
2.0 | 5.9 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
1.9 | 11.4 | GO:0090166 | Golgi disassembly(GO:0090166) |
1.9 | 1.9 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
1.9 | 5.7 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
1.9 | 7.5 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
1.9 | 5.6 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
1.8 | 7.3 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
1.8 | 5.5 | GO:0070295 | renal water absorption(GO:0070295) |
1.8 | 5.5 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.8 | 7.3 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
1.8 | 10.8 | GO:0090527 | actin filament reorganization(GO:0090527) |
1.8 | 5.4 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
1.8 | 1.8 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
1.8 | 1.8 | GO:0046084 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
1.8 | 7.1 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
1.8 | 5.3 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
1.8 | 5.3 | GO:0060847 | endothelial cell fate specification(GO:0060847) |
1.7 | 8.7 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
1.7 | 5.2 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
1.7 | 14.0 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
1.7 | 7.0 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
1.7 | 1.7 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
1.7 | 1.7 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
1.7 | 3.4 | GO:0006868 | glutamine transport(GO:0006868) |
1.7 | 5.1 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
1.7 | 6.8 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
1.7 | 8.4 | GO:0071763 | nuclear membrane organization(GO:0071763) |
1.7 | 5.0 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
1.7 | 36.8 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
1.7 | 1.7 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
1.6 | 1.6 | GO:0006551 | leucine metabolic process(GO:0006551) |
1.6 | 6.6 | GO:0006848 | pyruvate transport(GO:0006848) |
1.6 | 11.5 | GO:0046040 | IMP metabolic process(GO:0046040) |
1.6 | 8.1 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
1.6 | 9.8 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
1.6 | 4.9 | GO:0002432 | granuloma formation(GO:0002432) |
1.6 | 4.8 | GO:0010040 | response to iron(II) ion(GO:0010040) |
1.6 | 9.6 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
1.6 | 4.8 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
1.6 | 1.6 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
1.6 | 4.8 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
1.6 | 3.2 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
1.6 | 4.8 | GO:1903286 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
1.6 | 9.5 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
1.6 | 6.3 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
1.6 | 1.6 | GO:0015817 | histidine transport(GO:0015817) |
1.6 | 6.3 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
1.6 | 3.1 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
1.5 | 10.8 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
1.5 | 3.1 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
1.5 | 1.5 | GO:1903147 | negative regulation of mitophagy(GO:1903147) |
1.5 | 1.5 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
1.5 | 6.1 | GO:0070627 | ferrous iron import(GO:0070627) ferrous iron import into cell(GO:0097460) |
1.5 | 7.6 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
1.5 | 1.5 | GO:0018904 | ether metabolic process(GO:0018904) |
1.5 | 4.6 | GO:2001225 | regulation of chloride transport(GO:2001225) |
1.5 | 4.5 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
1.5 | 4.5 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
1.5 | 12.1 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
1.5 | 7.5 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
1.5 | 3.0 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
1.5 | 3.0 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
1.5 | 8.9 | GO:0006561 | proline biosynthetic process(GO:0006561) |
1.5 | 10.3 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
1.5 | 4.4 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
1.5 | 5.9 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
1.5 | 4.4 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
1.5 | 16.1 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
1.5 | 1.5 | GO:0046049 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
1.5 | 5.8 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
1.5 | 5.8 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
1.5 | 5.8 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
1.4 | 8.7 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
1.4 | 14.4 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
1.4 | 4.3 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
1.4 | 1.4 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
1.4 | 5.7 | GO:0090168 | Golgi reassembly(GO:0090168) |
1.4 | 4.3 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
1.4 | 2.8 | GO:0046061 | dATP catabolic process(GO:0046061) |
1.4 | 16.9 | GO:0030449 | regulation of complement activation(GO:0030449) |
1.4 | 4.2 | GO:0009597 | detection of virus(GO:0009597) |
1.4 | 2.8 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
1.4 | 5.6 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
1.4 | 1.4 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
1.4 | 4.2 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
1.4 | 2.8 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
1.4 | 8.3 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
1.4 | 1.4 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
1.4 | 4.1 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
1.4 | 1.4 | GO:0009211 | pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) |
1.4 | 5.5 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
1.4 | 2.7 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
1.4 | 4.1 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
1.4 | 13.6 | GO:0043249 | erythrocyte maturation(GO:0043249) |
1.4 | 2.7 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
1.4 | 5.4 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
1.3 | 16.2 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
1.3 | 5.4 | GO:0051541 | elastin metabolic process(GO:0051541) |
1.3 | 1.3 | GO:0032672 | regulation of interleukin-3 production(GO:0032672) |
1.3 | 5.3 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
1.3 | 2.7 | GO:0043173 | nucleotide salvage(GO:0043173) |
1.3 | 4.0 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
1.3 | 2.7 | GO:0015684 | ferrous iron transport(GO:0015684) |
1.3 | 11.9 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
1.3 | 4.0 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
1.3 | 1.3 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
1.3 | 2.6 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
1.3 | 4.0 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
1.3 | 4.0 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
1.3 | 3.9 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
1.3 | 3.9 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
1.3 | 3.9 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
1.3 | 6.5 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
1.3 | 14.3 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
1.3 | 9.1 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
1.3 | 9.1 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
1.3 | 6.5 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
1.3 | 3.9 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
1.3 | 3.9 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
1.3 | 3.8 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.3 | 2.6 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
1.3 | 1.3 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
1.3 | 5.1 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
1.3 | 3.8 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
1.3 | 6.3 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
1.3 | 17.6 | GO:0048821 | erythrocyte development(GO:0048821) |
1.3 | 2.5 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
1.3 | 7.6 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
1.3 | 3.8 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
1.3 | 1.3 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
1.3 | 3.8 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
1.3 | 6.3 | GO:0019695 | choline metabolic process(GO:0019695) |
1.3 | 3.8 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.2 | 1.2 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
1.2 | 3.7 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
1.2 | 3.7 | GO:0000087 | mitotic M phase(GO:0000087) |
1.2 | 5.0 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
1.2 | 6.2 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
1.2 | 7.4 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
1.2 | 7.4 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
1.2 | 3.7 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
1.2 | 4.9 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
1.2 | 4.9 | GO:0006560 | proline metabolic process(GO:0006560) |
1.2 | 10.9 | GO:0051198 | negative regulation of nucleotide catabolic process(GO:0030812) negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
1.2 | 1.2 | GO:0035483 | gastric motility(GO:0035482) gastric emptying(GO:0035483) |
1.2 | 6.0 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
1.2 | 6.0 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
1.2 | 1.2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
1.2 | 8.4 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
1.2 | 6.0 | GO:0010424 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
1.2 | 10.8 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
1.2 | 3.6 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
1.2 | 13.1 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
1.2 | 3.6 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
1.2 | 3.6 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
1.2 | 1.2 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
1.2 | 1.2 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
1.2 | 23.5 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
1.2 | 18.7 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
1.2 | 4.7 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
1.2 | 3.5 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
1.2 | 5.8 | GO:0070475 | rRNA base methylation(GO:0070475) |
1.2 | 2.3 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
1.2 | 9.3 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
1.2 | 3.5 | GO:0042117 | monocyte activation(GO:0042117) |
1.2 | 3.5 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
1.2 | 2.3 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
1.1 | 4.6 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
1.1 | 5.7 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
1.1 | 5.7 | GO:0019627 | urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
1.1 | 5.7 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
1.1 | 2.3 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
1.1 | 3.4 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
1.1 | 3.4 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
1.1 | 3.4 | GO:0000212 | meiotic spindle organization(GO:0000212) |
1.1 | 3.4 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
1.1 | 3.4 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
1.1 | 2.2 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
1.1 | 3.4 | GO:0015886 | heme transport(GO:0015886) |
1.1 | 1.1 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
1.1 | 6.6 | GO:0040016 | embryonic cleavage(GO:0040016) |
1.1 | 3.3 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
1.1 | 4.4 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
1.1 | 1.1 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
1.1 | 1.1 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
1.1 | 13.2 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
1.1 | 3.3 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.1 | 2.2 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
1.1 | 2.2 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
1.1 | 3.3 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
1.1 | 5.4 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
1.1 | 1.1 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
1.1 | 3.3 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
1.1 | 2.2 | GO:1901563 | response to camptothecin(GO:1901563) |
1.1 | 3.2 | GO:1990034 | calcium ion export from cell(GO:1990034) |
1.1 | 1.1 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
1.1 | 2.1 | GO:0014745 | negative regulation of muscle adaptation(GO:0014745) |
1.1 | 1.1 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
1.1 | 1.1 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
1.1 | 3.2 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
1.1 | 1.1 | GO:1903273 | regulation of sodium ion export(GO:1903273) regulation of sodium ion export from cell(GO:1903276) |
1.1 | 6.3 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
1.1 | 2.1 | GO:1903984 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
1.0 | 1.0 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
1.0 | 3.1 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
1.0 | 2.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
1.0 | 8.3 | GO:0035855 | megakaryocyte development(GO:0035855) |
1.0 | 3.1 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
1.0 | 1.0 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
1.0 | 5.2 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
1.0 | 4.1 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
1.0 | 5.2 | GO:0009642 | response to light intensity(GO:0009642) |
1.0 | 3.1 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
1.0 | 4.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
1.0 | 1.0 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
1.0 | 6.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
1.0 | 1.0 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
1.0 | 2.0 | GO:0032803 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
1.0 | 2.0 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
1.0 | 3.0 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
1.0 | 6.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
1.0 | 4.0 | GO:0071494 | cellular response to UV-C(GO:0071494) |
1.0 | 3.0 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
1.0 | 5.1 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
1.0 | 6.0 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
1.0 | 3.0 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
1.0 | 9.0 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
1.0 | 5.0 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
1.0 | 2.0 | GO:0097167 | circadian regulation of translation(GO:0097167) |
1.0 | 4.9 | GO:0008090 | retrograde axonal transport(GO:0008090) |
1.0 | 2.0 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
1.0 | 2.0 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
1.0 | 1.0 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
1.0 | 5.9 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
1.0 | 4.9 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
1.0 | 1.9 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
1.0 | 2.9 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
1.0 | 3.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.0 | 1.0 | GO:0032898 | neurotrophin production(GO:0032898) |
1.0 | 10.6 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
1.0 | 5.8 | GO:0034063 | stress granule assembly(GO:0034063) |
1.0 | 1.0 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
1.0 | 5.8 | GO:0060613 | fat pad development(GO:0060613) |
1.0 | 3.8 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
1.0 | 4.8 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
1.0 | 1.0 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
1.0 | 2.9 | GO:0030421 | defecation(GO:0030421) |
0.9 | 16.1 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.9 | 4.7 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.9 | 4.7 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.9 | 2.8 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.9 | 44.2 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.9 | 2.8 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.9 | 6.6 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.9 | 1.9 | GO:0032202 | telomere assembly(GO:0032202) |
0.9 | 3.7 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.9 | 1.9 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.9 | 1.9 | GO:0010182 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.9 | 12.1 | GO:0042730 | fibrinolysis(GO:0042730) |
0.9 | 2.8 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.9 | 0.9 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.9 | 2.8 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.9 | 0.9 | GO:1901536 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.9 | 6.5 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.9 | 5.6 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.9 | 3.7 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.9 | 2.8 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.9 | 1.8 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.9 | 0.9 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.9 | 10.1 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.9 | 1.8 | GO:1902219 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.9 | 5.5 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.9 | 4.6 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.9 | 3.7 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.9 | 2.7 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.9 | 0.9 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.9 | 13.5 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.9 | 3.6 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.9 | 6.3 | GO:0090208 | positive regulation of triglyceride metabolic process(GO:0090208) |
0.9 | 7.2 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.9 | 1.8 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
0.9 | 2.7 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.9 | 0.9 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.9 | 4.5 | GO:0033572 | transferrin transport(GO:0033572) |
0.9 | 2.7 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.9 | 3.6 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.9 | 3.6 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.9 | 1.8 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.9 | 0.9 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.9 | 1.8 | GO:0060057 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.9 | 9.8 | GO:0043248 | proteasome assembly(GO:0043248) |
0.9 | 4.4 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.9 | 17.7 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.9 | 2.7 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.9 | 7.1 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.9 | 1.8 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.9 | 0.9 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.9 | 2.6 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.9 | 0.9 | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.9 | 1.7 | GO:0030242 | pexophagy(GO:0030242) |
0.9 | 1.7 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
0.9 | 0.9 | GO:0070671 | response to interleukin-12(GO:0070671) |
0.9 | 4.3 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.9 | 0.9 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.9 | 2.6 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.9 | 2.6 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.9 | 6.9 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.9 | 0.9 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.9 | 1.7 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.9 | 3.4 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.9 | 8.5 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.9 | 1.7 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.9 | 5.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.8 | 2.5 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.8 | 3.4 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.8 | 10.2 | GO:0051601 | exocyst localization(GO:0051601) |
0.8 | 4.2 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.8 | 2.5 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.8 | 2.5 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.8 | 4.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.8 | 5.9 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.8 | 4.2 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.8 | 3.4 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.8 | 3.3 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.8 | 3.3 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.8 | 5.0 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.8 | 3.3 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.8 | 9.1 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.8 | 2.5 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.8 | 0.8 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
0.8 | 2.5 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.8 | 6.6 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.8 | 5.7 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.8 | 0.8 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.8 | 14.7 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.8 | 6.5 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.8 | 4.9 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.8 | 0.8 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.8 | 1.6 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.8 | 2.4 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.8 | 1.6 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.8 | 8.9 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.8 | 5.7 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.8 | 4.0 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.8 | 5.7 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.8 | 4.0 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.8 | 13.7 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.8 | 0.8 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.8 | 1.6 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.8 | 3.2 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.8 | 0.8 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.8 | 0.8 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.8 | 1.6 | GO:0060558 | regulation of calcidiol 1-monooxygenase activity(GO:0060558) |
0.8 | 4.8 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.8 | 0.8 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.8 | 3.9 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.8 | 3.1 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.8 | 5.5 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.8 | 12.5 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
0.8 | 14.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.8 | 2.3 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.8 | 0.8 | GO:0007031 | peroxisome organization(GO:0007031) |
0.8 | 0.8 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.8 | 0.8 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.8 | 2.3 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.8 | 1.6 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
0.8 | 3.9 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.8 | 1.6 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.8 | 1.6 | GO:0060056 | mammary gland involution(GO:0060056) |
0.8 | 7.7 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.8 | 3.1 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.8 | 1.5 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.8 | 0.8 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.8 | 0.8 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.8 | 2.3 | GO:1902101 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.8 | 1.5 | GO:1990874 | regulation of vascular smooth muscle cell proliferation(GO:1904705) positive regulation of vascular smooth muscle cell proliferation(GO:1904707) vascular smooth muscle cell proliferation(GO:1990874) |
0.8 | 3.1 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.8 | 3.1 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.8 | 1.5 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.8 | 3.1 | GO:0046464 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
0.8 | 4.6 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.8 | 2.3 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.8 | 3.1 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.8 | 3.8 | GO:0046503 | glycerolipid catabolic process(GO:0046503) |
0.8 | 4.6 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.8 | 1.5 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.8 | 22.6 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.8 | 5.3 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.7 | 5.2 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.7 | 3.7 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.7 | 2.2 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.7 | 1.5 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.7 | 0.7 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.7 | 3.0 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.7 | 3.0 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.7 | 3.0 | GO:0018214 | protein carboxylation(GO:0018214) |
0.7 | 6.7 | GO:0009148 | pyrimidine nucleoside triphosphate biosynthetic process(GO:0009148) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleotide biosynthetic process(GO:0009220) pyrimidine ribonucleoside biosynthetic process(GO:0046132) |
0.7 | 4.4 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.7 | 2.9 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.7 | 3.7 | GO:0030852 | regulation of granulocyte differentiation(GO:0030852) |
0.7 | 3.7 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.7 | 2.9 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.7 | 1.5 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.7 | 4.4 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.7 | 2.9 | GO:0009838 | abscission(GO:0009838) |
0.7 | 0.7 | GO:0009218 | pyrimidine ribonucleotide metabolic process(GO:0009218) |
0.7 | 1.5 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.7 | 2.9 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.7 | 3.6 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.7 | 2.2 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.7 | 2.2 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.7 | 2.9 | GO:0072528 | pyrimidine-containing compound biosynthetic process(GO:0072528) |
0.7 | 0.7 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.7 | 1.4 | GO:0033131 | regulation of glucokinase activity(GO:0033131) regulation of hexokinase activity(GO:1903299) |
0.7 | 2.2 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.7 | 6.5 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.7 | 2.9 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.7 | 7.9 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.7 | 1.4 | GO:0072718 | response to cisplatin(GO:0072718) |
0.7 | 7.9 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.7 | 1.4 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.7 | 0.7 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.7 | 6.4 | GO:0009301 | snRNA transcription(GO:0009301) |
0.7 | 1.4 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.7 | 5.7 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.7 | 4.2 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.7 | 1.4 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.7 | 2.1 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.7 | 2.1 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.7 | 8.5 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.7 | 1.4 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
0.7 | 4.2 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.7 | 4.2 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.7 | 0.7 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) |
0.7 | 3.5 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.7 | 4.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.7 | 9.0 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.7 | 0.7 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.7 | 4.9 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.7 | 1.4 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.7 | 0.7 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.7 | 1.4 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.7 | 4.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.7 | 2.8 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.7 | 1.4 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.7 | 13.8 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.7 | 1.4 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) |
0.7 | 1.4 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.7 | 0.7 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.7 | 3.4 | GO:0014010 | regulation of Schwann cell proliferation(GO:0010624) Schwann cell proliferation(GO:0014010) |
0.7 | 2.0 | GO:0090148 | membrane fission(GO:0090148) |
0.7 | 2.0 | GO:0015888 | thiamine transport(GO:0015888) |
0.7 | 0.7 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
0.7 | 8.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.7 | 2.0 | GO:0060525 | prostate glandular acinus development(GO:0060525) |
0.7 | 2.0 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.7 | 0.7 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.7 | 6.0 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.7 | 1.3 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.7 | 0.7 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.7 | 2.0 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.7 | 1.3 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.7 | 4.0 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.7 | 6.0 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.7 | 1.3 | GO:0002215 | defense response to nematode(GO:0002215) |
0.7 | 0.7 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.7 | 6.0 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.7 | 3.3 | GO:1904666 | regulation of ubiquitin protein ligase activity(GO:1904666) positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.7 | 0.7 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.7 | 4.0 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.7 | 7.9 | GO:0006465 | signal peptide processing(GO:0006465) |
0.7 | 1.3 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.7 | 1.3 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.7 | 3.3 | GO:0042168 | heme metabolic process(GO:0042168) |
0.7 | 3.9 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.7 | 7.9 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.7 | 1.3 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.7 | 2.0 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.7 | 5.2 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.7 | 2.0 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.7 | 2.0 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.7 | 7.8 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.7 | 2.6 | GO:0015671 | oxygen transport(GO:0015671) |
0.7 | 2.6 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.6 | 3.2 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.6 | 0.6 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.6 | 3.9 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.6 | 3.2 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.6 | 2.6 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.6 | 14.2 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.6 | 1.3 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.6 | 4.5 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.6 | 1.9 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.6 | 0.6 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.6 | 7.7 | GO:0044819 | mitotic G1 DNA damage checkpoint(GO:0031571) mitotic G1/S transition checkpoint(GO:0044819) |
0.6 | 3.2 | GO:0016559 | peroxisome fission(GO:0016559) |
0.6 | 1.9 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.6 | 7.0 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.6 | 0.6 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.6 | 1.3 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.6 | 0.6 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.6 | 3.2 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.6 | 1.3 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.6 | 2.5 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.6 | 5.1 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.6 | 0.6 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.6 | 1.9 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.6 | 1.9 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.6 | 4.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.6 | 3.8 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.6 | 1.3 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.6 | 4.4 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.6 | 3.1 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.6 | 0.6 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.6 | 1.2 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.6 | 6.2 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.6 | 1.2 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.6 | 1.2 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.6 | 4.3 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
0.6 | 1.2 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.6 | 0.6 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.6 | 0.6 | GO:2000257 | regulation of protein activation cascade(GO:2000257) |
0.6 | 3.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.6 | 19.1 | GO:0051306 | mitotic sister chromatid separation(GO:0051306) |
0.6 | 0.6 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
0.6 | 3.1 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.6 | 0.6 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.6 | 1.8 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.6 | 1.8 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.6 | 3.1 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.6 | 6.1 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.6 | 1.2 | GO:0046486 | glycerolipid metabolic process(GO:0046486) |
0.6 | 2.4 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.6 | 2.4 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.6 | 1.2 | GO:0002159 | desmosome assembly(GO:0002159) |
0.6 | 1.8 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.6 | 2.4 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.6 | 7.8 | GO:0045116 | protein neddylation(GO:0045116) |
0.6 | 1.2 | GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.6 | 1.8 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.6 | 6.6 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.6 | 1.8 | GO:0007127 | meiosis I(GO:0007127) |
0.6 | 3.6 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.6 | 1.8 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.6 | 1.2 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.6 | 3.0 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.6 | 1.8 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.6 | 4.7 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.6 | 1.2 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.6 | 0.6 | GO:2000058 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000058) |
0.6 | 2.4 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.6 | 2.9 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.6 | 4.7 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.6 | 1.8 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.6 | 1.2 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.6 | 1.2 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.6 | 1.2 | GO:0051985 | negative regulation of chromosome segregation(GO:0051985) |
0.6 | 2.3 | GO:0019532 | oxalate transport(GO:0019532) |
0.6 | 1.8 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.6 | 1.8 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.6 | 5.8 | GO:0001675 | acrosome assembly(GO:0001675) |
0.6 | 4.1 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.6 | 4.1 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.6 | 2.3 | GO:0051126 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.6 | 1.2 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.6 | 5.2 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.6 | 1.7 | GO:0001302 | replicative cell aging(GO:0001302) |
0.6 | 1.7 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.6 | 2.3 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.6 | 1.7 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.6 | 1.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.6 | 0.6 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.6 | 6.4 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.6 | 1.7 | GO:0003383 | apical constriction(GO:0003383) |
0.6 | 3.5 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.6 | 1.2 | GO:0071025 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.6 | 2.3 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.6 | 1.1 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.6 | 4.6 | GO:0006458 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.6 | 1.1 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.6 | 4.0 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.6 | 6.3 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.6 | 2.3 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.6 | 2.3 | GO:0044794 | positive regulation by host of viral process(GO:0044794) |
0.6 | 1.1 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.6 | 3.4 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.6 | 5.1 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
0.6 | 2.3 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.6 | 1.7 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.6 | 1.7 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.6 | 1.7 | GO:1901185 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.6 | 1.7 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.6 | 0.6 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.6 | 1.7 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.6 | 1.7 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.6 | 11.7 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.6 | 2.8 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.6 | 2.2 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.6 | 2.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.6 | 0.6 | GO:0051444 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.6 | 3.3 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.6 | 1.1 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.6 | 8.9 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.6 | 0.6 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.6 | 5.5 | GO:2000641 | regulation of early endosome to late endosome transport(GO:2000641) |
0.6 | 1.7 | GO:0006573 | valine metabolic process(GO:0006573) |
0.6 | 1.7 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.6 | 1.1 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.6 | 0.6 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.6 | 0.6 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.6 | 1.1 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.5 | 2.2 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.5 | 4.9 | GO:0008272 | sulfate transport(GO:0008272) |
0.5 | 2.2 | GO:0015871 | choline transport(GO:0015871) |
0.5 | 3.8 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.5 | 3.8 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.5 | 0.5 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.5 | 2.7 | GO:0051013 | microtubule severing(GO:0051013) |
0.5 | 2.2 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.5 | 3.8 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.5 | 2.2 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.5 | 0.5 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.5 | 0.5 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.5 | 2.7 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.5 | 1.1 | GO:0043091 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.5 | 1.1 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.5 | 1.1 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) positive regulation of histone H3-K27 methylation(GO:0061087) |
0.5 | 1.1 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.5 | 0.5 | GO:0032439 | endosome localization(GO:0032439) |
0.5 | 1.1 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.5 | 1.6 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.5 | 1.6 | GO:0044351 | macropinocytosis(GO:0044351) |
0.5 | 1.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.5 | 0.5 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.5 | 2.1 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.5 | 1.1 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.5 | 0.5 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.5 | 3.2 | GO:0002591 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.5 | 10.0 | GO:0007569 | cell aging(GO:0007569) |
0.5 | 11.5 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.5 | 2.1 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.5 | 0.5 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.5 | 1.6 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.5 | 1.0 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.5 | 1.6 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.5 | 1.6 | GO:0015705 | iodide transport(GO:0015705) |
0.5 | 1.6 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.5 | 0.5 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.5 | 5.2 | GO:0072662 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.5 | 3.1 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.5 | 0.5 | GO:0010915 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.5 | 4.1 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.5 | 1.0 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.5 | 1.0 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.5 | 0.5 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.5 | 1.5 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.5 | 1.0 | GO:0021564 | vagus nerve development(GO:0021564) |
0.5 | 2.0 | GO:0015074 | DNA integration(GO:0015074) |
0.5 | 18.3 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.5 | 1.5 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.5 | 4.6 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.5 | 1.0 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.5 | 2.0 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.5 | 3.6 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.5 | 0.5 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.5 | 0.5 | GO:0032891 | negative regulation of organic acid transport(GO:0032891) |
0.5 | 3.5 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.5 | 3.5 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.5 | 7.6 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
0.5 | 0.5 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) negative regulation of bicellular tight junction assembly(GO:1903347) |
0.5 | 1.5 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.5 | 2.5 | GO:1902713 | regulation of interferon-gamma secretion(GO:1902713) |
0.5 | 2.0 | GO:0007000 | nucleolus organization(GO:0007000) |
0.5 | 0.5 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.5 | 5.5 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.5 | 0.5 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.5 | 0.5 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.5 | 4.5 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.5 | 1.5 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.5 | 0.5 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.5 | 1.5 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.5 | 0.5 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.5 | 3.0 | GO:0051026 | chiasma assembly(GO:0051026) |
0.5 | 1.0 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.5 | 1.0 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.5 | 0.5 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.5 | 1.0 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
0.5 | 1.5 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.5 | 2.4 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.5 | 2.4 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.5 | 1.9 | GO:0007296 | vitellogenesis(GO:0007296) |
0.5 | 2.4 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.5 | 2.4 | GO:0016266 | O-glycan processing(GO:0016266) |
0.5 | 1.0 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.5 | 2.4 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.5 | 1.4 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.5 | 1.0 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.5 | 0.5 | GO:0075136 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.5 | 3.3 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.5 | 4.8 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.5 | 1.4 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.5 | 0.9 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.5 | 3.3 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.5 | 2.4 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.5 | 2.4 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.5 | 1.4 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.5 | 0.5 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.5 | 0.5 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.5 | 0.9 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.5 | 1.9 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.5 | 1.4 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.5 | 12.6 | GO:0006638 | neutral lipid metabolic process(GO:0006638) |
0.5 | 0.9 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.5 | 0.9 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.5 | 3.7 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.5 | 0.5 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.5 | 0.9 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.5 | 3.2 | GO:0006903 | vesicle targeting(GO:0006903) |
0.5 | 3.2 | GO:0031100 | organ regeneration(GO:0031100) |
0.5 | 6.4 | GO:0006396 | RNA processing(GO:0006396) |
0.5 | 1.8 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.5 | 0.9 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.5 | 3.2 | GO:0007097 | nuclear migration(GO:0007097) |
0.5 | 6.4 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.5 | 0.9 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.5 | 2.3 | GO:0009249 | protein lipoylation(GO:0009249) |
0.5 | 1.4 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.5 | 1.4 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.5 | 0.5 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.5 | 1.8 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.5 | 1.4 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.5 | 0.5 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.5 | 0.9 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.4 | 0.9 | GO:0048254 | snoRNA localization(GO:0048254) |
0.4 | 0.4 | GO:0061724 | lipophagy(GO:0061724) |
0.4 | 0.9 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
0.4 | 0.9 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.4 | 3.1 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.4 | 0.4 | GO:0009151 | purine deoxyribonucleotide metabolic process(GO:0009151) |
0.4 | 0.9 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.4 | 1.8 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.4 | 3.1 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.4 | 1.3 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.4 | 0.9 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.4 | 1.3 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
0.4 | 4.4 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.4 | 1.7 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.4 | 1.7 | GO:0042546 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule metabolic process(GO:0044036) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) cell wall organization or biogenesis(GO:0071554) |
0.4 | 4.8 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.4 | 0.9 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.4 | 2.6 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.4 | 3.9 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.4 | 1.3 | GO:0006116 | NADH oxidation(GO:0006116) |
0.4 | 1.7 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.4 | 1.7 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.4 | 1.3 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.4 | 4.3 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.4 | 0.9 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.4 | 3.4 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.4 | 5.1 | GO:0098534 | centriole assembly(GO:0098534) |
0.4 | 1.7 | GO:0046415 | urate metabolic process(GO:0046415) |
0.4 | 5.1 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.4 | 6.4 | GO:0006301 | postreplication repair(GO:0006301) |
0.4 | 4.7 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.4 | 0.4 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.4 | 0.8 | GO:0006569 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.4 | 3.8 | GO:0070269 | pyroptosis(GO:0070269) |
0.4 | 5.0 | GO:1900077 | negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.4 | 0.8 | GO:0050711 | negative regulation of interleukin-1 secretion(GO:0050711) |
0.4 | 0.8 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.4 | 16.7 | GO:0051225 | spindle assembly(GO:0051225) |
0.4 | 5.4 | GO:0032392 | DNA geometric change(GO:0032392) |
0.4 | 1.2 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.4 | 0.4 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.4 | 4.6 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.4 | 1.2 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.4 | 0.4 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.4 | 12.8 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.4 | 19.7 | GO:0007030 | Golgi organization(GO:0007030) |
0.4 | 1.6 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.4 | 9.9 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.4 | 1.2 | GO:0015808 | L-alanine transport(GO:0015808) |
0.4 | 2.0 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.4 | 3.7 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.4 | 0.4 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.4 | 0.4 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.4 | 1.2 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.4 | 2.0 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.4 | 3.7 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.4 | 4.5 | GO:0016180 | snRNA processing(GO:0016180) |
0.4 | 0.4 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.4 | 5.7 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.4 | 0.4 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
0.4 | 0.8 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.4 | 8.8 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.4 | 6.4 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.4 | 2.0 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.4 | 0.4 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.4 | 0.8 | GO:0050832 | defense response to fungus(GO:0050832) |
0.4 | 1.6 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.4 | 0.4 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.4 | 0.4 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
0.4 | 0.8 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.4 | 1.6 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.4 | 0.4 | GO:0070417 | cellular response to cold(GO:0070417) |
0.4 | 3.5 | GO:1903363 | negative regulation of cellular protein catabolic process(GO:1903363) |
0.4 | 0.4 | GO:0009750 | response to fructose(GO:0009750) |
0.4 | 0.4 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.4 | 2.3 | GO:0035384 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
0.4 | 0.4 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.4 | 1.5 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.4 | 13.5 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.4 | 1.5 | GO:0080009 | mRNA methylation(GO:0080009) |
0.4 | 0.4 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.4 | 0.4 | GO:0051709 | regulation of killing of cells of other organism(GO:0051709) |
0.4 | 0.4 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
0.4 | 1.1 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.4 | 4.9 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.4 | 0.8 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.4 | 1.5 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.4 | 0.4 | GO:1903312 | negative regulation of mRNA metabolic process(GO:1903312) |
0.4 | 2.6 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.4 | 1.1 | GO:1903052 | positive regulation of proteolysis involved in cellular protein catabolic process(GO:1903052) |
0.4 | 1.5 | GO:0007143 | female meiotic division(GO:0007143) |
0.4 | 3.8 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.4 | 4.9 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.4 | 0.4 | GO:2000551 | regulation of T-helper 2 cell cytokine production(GO:2000551) positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.4 | 0.7 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.4 | 1.1 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.4 | 1.5 | GO:0033753 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.4 | 1.5 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.4 | 0.7 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.4 | 1.8 | GO:0061450 | trophoblast cell migration(GO:0061450) |
0.4 | 1.5 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.4 | 0.4 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.4 | 2.6 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.4 | 0.4 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.4 | 0.4 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.4 | 0.7 | GO:0048478 | replication fork protection(GO:0048478) |
0.4 | 1.8 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.4 | 1.1 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.4 | 0.7 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.4 | 2.9 | GO:1902117 | positive regulation of organelle assembly(GO:1902117) |
0.4 | 3.3 | GO:0060285 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.4 | 0.7 | GO:0048242 | epinephrine secretion(GO:0048242) |
0.4 | 0.7 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.4 | 4.7 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.4 | 0.7 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.4 | 2.5 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.4 | 6.9 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.4 | 1.4 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.4 | 0.4 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.4 | 0.7 | GO:1902075 | cellular response to salt(GO:1902075) |
0.4 | 1.8 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.4 | 4.3 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.4 | 2.1 | GO:0030575 | nuclear body organization(GO:0030575) |
0.4 | 1.4 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.4 | 0.7 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.4 | 1.4 | GO:0090151 | establishment of protein localization to mitochondrial membrane(GO:0090151) |
0.4 | 1.8 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.4 | 7.8 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.4 | 1.4 | GO:0036233 | glycine import(GO:0036233) |
0.4 | 1.8 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.4 | 13.0 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.4 | 0.4 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) response to high density lipoprotein particle(GO:0055099) |
0.3 | 2.1 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.3 | 2.1 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.3 | 0.3 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.3 | 1.0 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.3 | 1.0 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.3 | 1.4 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.3 | 0.3 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.3 | 6.2 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.3 | 1.0 | GO:0070266 | necroptotic process(GO:0070266) |
0.3 | 1.0 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
0.3 | 0.3 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.3 | 0.3 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.3 | 1.0 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.3 | 2.0 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.3 | 3.4 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.3 | 1.4 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.3 | 0.7 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.3 | 0.3 | GO:0009299 | mRNA transcription(GO:0009299) |
0.3 | 0.7 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.3 | 4.4 | GO:0007141 | male meiosis I(GO:0007141) |
0.3 | 3.7 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.3 | 5.0 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.3 | 3.7 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.3 | 1.0 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.3 | 8.6 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.3 | 0.3 | GO:0001555 | oocyte growth(GO:0001555) |
0.3 | 7.3 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.3 | 1.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.3 | 4.9 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.3 | 0.7 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.3 | 1.3 | GO:1900193 | regulation of oocyte maturation(GO:1900193) negative regulation of oocyte maturation(GO:1900194) |
0.3 | 1.3 | GO:0032881 | regulation of polysaccharide metabolic process(GO:0032881) |
0.3 | 7.5 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.3 | 1.3 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.3 | 5.5 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.3 | 0.6 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.3 | 4.5 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.3 | 0.3 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
0.3 | 0.6 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.3 | 1.6 | GO:0046697 | decidualization(GO:0046697) |
0.3 | 4.5 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.3 | 1.0 | GO:0010225 | response to UV-C(GO:0010225) |
0.3 | 2.9 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.3 | 1.6 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.3 | 0.6 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.3 | 4.5 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.3 | 4.4 | GO:0030488 | tRNA methylation(GO:0030488) |
0.3 | 1.0 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.3 | 0.9 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.3 | 1.3 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.3 | 0.6 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.3 | 2.8 | GO:0000154 | rRNA modification(GO:0000154) |
0.3 | 2.2 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.3 | 2.5 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.3 | 0.3 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) |
0.3 | 2.2 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.3 | 2.8 | GO:0032418 | lysosome localization(GO:0032418) |
0.3 | 0.6 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.3 | 0.9 | GO:0035646 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.3 | 0.3 | GO:0002585 | positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) |
0.3 | 2.8 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.3 | 9.5 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) |
0.3 | 0.9 | GO:2000851 | positive regulation of glucocorticoid secretion(GO:2000851) |
0.3 | 1.2 | GO:0051031 | tRNA transport(GO:0051031) |
0.3 | 0.6 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.3 | 1.2 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.3 | 1.8 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.3 | 0.6 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.3 | 2.1 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.3 | 0.6 | GO:0052472 | modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
0.3 | 0.6 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.3 | 3.9 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.3 | 1.2 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.3 | 0.9 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.3 | 0.6 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.3 | 0.9 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.3 | 8.4 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.3 | 2.4 | GO:0051168 | nuclear export(GO:0051168) |
0.3 | 1.5 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.3 | 2.4 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.3 | 0.9 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.3 | 3.0 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.3 | 1.2 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.3 | 5.3 | GO:0006414 | translational elongation(GO:0006414) |
0.3 | 1.5 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.3 | 1.5 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.3 | 0.3 | GO:0072603 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
0.3 | 0.3 | GO:0015669 | gas transport(GO:0015669) |
0.3 | 2.3 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.3 | 0.3 | GO:0006415 | translational termination(GO:0006415) |
0.3 | 8.2 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.3 | 1.5 | GO:1903901 | negative regulation of viral life cycle(GO:1903901) |
0.3 | 1.2 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.3 | 0.3 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.3 | 0.6 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.3 | 2.3 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.3 | 4.6 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.3 | 1.4 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.3 | 0.3 | GO:0006568 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.3 | 0.3 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.3 | 0.3 | GO:0019080 | viral gene expression(GO:0019080) |
0.3 | 1.1 | GO:1903867 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.3 | 3.1 | GO:0006491 | N-glycan processing(GO:0006491) |
0.3 | 0.9 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.3 | 2.6 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
0.3 | 1.1 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.3 | 1.7 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.3 | 0.6 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.3 | 13.6 | GO:0008033 | tRNA processing(GO:0008033) |
0.3 | 0.6 | GO:0006323 | DNA packaging(GO:0006323) |
0.3 | 0.6 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.3 | 0.3 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.3 | 4.2 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.3 | 3.1 | GO:0051297 | centrosome organization(GO:0051297) |
0.3 | 2.5 | GO:0042407 | cristae formation(GO:0042407) |
0.3 | 4.4 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.3 | 0.3 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.3 | 0.8 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.3 | 0.6 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.3 | 2.5 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.3 | 0.3 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.3 | 0.8 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.3 | 4.9 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.3 | 0.3 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.3 | 0.5 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.3 | 5.2 | GO:0051028 | mRNA transport(GO:0051028) |
0.3 | 12.2 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.3 | 0.3 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.3 | 2.7 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.3 | 0.3 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.3 | 2.1 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.3 | 0.3 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.3 | 0.3 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.3 | 0.3 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.3 | 0.8 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.3 | 0.3 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.3 | 1.9 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.3 | 3.2 | GO:0015893 | drug transport(GO:0015893) |
0.3 | 0.3 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) |
0.3 | 1.9 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.3 | 0.3 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.3 | 2.4 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.3 | 0.8 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.3 | 0.3 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.3 | 0.5 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.3 | 0.3 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.3 | 0.5 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.3 | 1.0 | GO:0000012 | single strand break repair(GO:0000012) |
0.3 | 0.5 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.3 | 1.0 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.3 | 0.3 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.3 | 0.8 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.3 | 1.3 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.3 | 0.8 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.3 | 3.3 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.3 | 0.5 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.3 | 0.3 | GO:0070391 | response to bacterial lipopeptide(GO:0070339) response to lipoteichoic acid(GO:0070391) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) cellular response to lipoteichoic acid(GO:0071223) response to diacyl bacterial lipopeptide(GO:0071724) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to diacyl bacterial lipopeptide(GO:0071726) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.3 | 1.0 | GO:0043620 | regulation of DNA-templated transcription in response to stress(GO:0043620) |
0.3 | 7.9 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.3 | 0.5 | GO:0035425 | autocrine signaling(GO:0035425) |
0.3 | 0.5 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.3 | 0.3 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.3 | 2.5 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.2 | 0.7 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.2 | 2.5 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.2 | 4.2 | GO:0006953 | acute-phase response(GO:0006953) |
0.2 | 2.0 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.2 | 3.2 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.2 | 0.5 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.2 | 2.0 | GO:0044804 | nucleophagy(GO:0044804) |
0.2 | 0.5 | GO:0060926 | atrioventricular node development(GO:0003162) cardiac pacemaker cell development(GO:0060926) |
0.2 | 0.2 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.2 | 3.2 | GO:1901998 | toxin transport(GO:1901998) |
0.2 | 1.2 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
0.2 | 0.2 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.2 | 1.0 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.2 | 0.5 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.2 | 1.0 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.2 | 0.2 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.2 | 0.5 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.2 | 0.7 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.2 | 0.5 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.2 | 0.7 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.2 | 0.5 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.2 | 5.9 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.2 | 1.2 | GO:0031297 | replication fork processing(GO:0031297) |
0.2 | 4.3 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.2 | 15.8 | GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process(GO:0043161) |
0.2 | 0.7 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.2 | 0.2 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.2 | 1.2 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.2 | 1.6 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.2 | 0.7 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.2 | 0.2 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.2 | 2.5 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.2 | 0.9 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.2 | 1.6 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.2 | 1.8 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
0.2 | 0.2 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.2 | 0.7 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.2 | 0.5 | GO:0015744 | succinate transport(GO:0015744) |
0.2 | 0.2 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.2 | 0.2 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.2 | 0.5 | GO:0007525 | somatic muscle development(GO:0007525) |
0.2 | 0.5 | GO:0031448 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.2 | 2.3 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.2 | 4.1 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.2 | 1.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.2 | 0.4 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.2 | 1.3 | GO:0045974 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.2 | 0.2 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.2 | 0.2 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.2 | 0.9 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.2 | 3.9 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.2 | 3.0 | GO:0090305 | nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
0.2 | 0.7 | GO:0046473 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.2 | 0.4 | GO:0046688 | response to copper ion(GO:0046688) |
0.2 | 0.6 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.2 | 0.6 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.2 | 0.4 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.2 | 4.3 | GO:0006413 | translational initiation(GO:0006413) |
0.2 | 0.6 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.2 | 2.6 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.2 | 2.1 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.2 | 0.2 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.2 | 1.3 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.2 | 1.5 | GO:0046514 | ceramide catabolic process(GO:0046514) |
0.2 | 0.8 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.2 | 0.6 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.2 | 1.5 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 1.3 | GO:0007088 | regulation of mitotic nuclear division(GO:0007088) |
0.2 | 5.2 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.2 | 2.1 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.2 | 2.5 | GO:0060142 | regulation of syncytium formation by plasma membrane fusion(GO:0060142) |
0.2 | 0.2 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.2 | 0.4 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.2 | 0.4 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.2 | 0.4 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.2 | 0.2 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.2 | 28.6 | GO:0008380 | RNA splicing(GO:0008380) |
0.2 | 0.2 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.2 | 1.8 | GO:0015858 | nucleoside transport(GO:0015858) |
0.2 | 0.4 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.2 | 0.2 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.2 | 4.1 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.2 | 11.8 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.2 | 0.4 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.2 | 0.2 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.2 | 0.6 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.2 | 0.2 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.2 | 0.6 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 0.4 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
0.2 | 1.0 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.2 | 0.8 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.2 | 0.6 | GO:0006968 | cellular defense response(GO:0006968) |
0.2 | 0.6 | GO:2000757 | negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.2 | 0.2 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.2 | 1.0 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.2 | 3.1 | GO:0016445 | somatic diversification of immunoglobulins(GO:0016445) |
0.2 | 0.4 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.2 | 0.8 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.2 | 0.8 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.2 | 0.2 | GO:0006298 | mismatch repair(GO:0006298) |
0.2 | 0.2 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) regulation of histone deacetylase activity(GO:1901725) |
0.2 | 0.2 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.2 | 1.3 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.2 | 0.4 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.2 | 13.2 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.2 | 1.7 | GO:0032965 | regulation of collagen biosynthetic process(GO:0032965) |
0.2 | 3.4 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.2 | 0.2 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.2 | 1.9 | GO:0017144 | drug metabolic process(GO:0017144) |
0.2 | 0.4 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.2 | 0.2 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.2 | 0.2 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.2 | 0.6 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.2 | 0.4 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.2 | 0.2 | GO:1990144 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.2 | 0.2 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.2 | 0.4 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.2 | 4.3 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.2 | 0.5 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.2 | 0.2 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.2 | 0.4 | GO:1900225 | regulation of NLRP3 inflammasome complex assembly(GO:1900225) |
0.2 | 0.2 | GO:0002775 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.2 | 0.7 | GO:0032098 | regulation of appetite(GO:0032098) |
0.2 | 3.6 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.2 | 0.5 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.2 | 0.5 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.2 | 0.5 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.2 | 0.2 | GO:0002467 | germinal center formation(GO:0002467) |
0.2 | 0.2 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.2 | 0.2 | GO:0002825 | regulation of T-helper 1 type immune response(GO:0002825) |
0.2 | 0.9 | GO:0048535 | lymph node development(GO:0048535) |
0.2 | 1.7 | GO:0007004 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.2 | 0.5 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.2 | 0.7 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.2 | 0.5 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.2 | 1.2 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.2 | 0.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.2 | 0.3 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.2 | 0.3 | GO:0072610 | interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
0.2 | 0.8 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.2 | 0.8 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.2 | 0.3 | GO:0010039 | response to iron ion(GO:0010039) |
0.2 | 0.2 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) |
0.2 | 0.5 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.2 | 0.3 | GO:0002586 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
0.2 | 0.5 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.2 | 0.3 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.2 | 1.0 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.2 | 0.2 | GO:1905214 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.2 | 0.5 | GO:0042026 | protein refolding(GO:0042026) |
0.2 | 0.3 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.2 | 0.2 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.2 | 0.5 | GO:0046782 | regulation of viral transcription(GO:0046782) |
0.2 | 0.5 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
0.2 | 1.1 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.2 | 0.2 | GO:0015755 | fructose transport(GO:0015755) |
0.2 | 1.4 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.2 | 0.3 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.2 | 0.2 | GO:0035973 | aggrephagy(GO:0035973) |
0.2 | 1.0 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.2 | 0.8 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.2 | 0.6 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.2 | 0.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.2 | 0.2 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.2 | 0.2 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.2 | 0.6 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.2 | 0.5 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.2 | 0.2 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.2 | 0.5 | GO:1904729 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
0.2 | 2.3 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.2 | 0.2 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.2 | 0.2 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.2 | 0.5 | GO:1902229 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) |
0.2 | 1.4 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.2 | 2.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.1 | GO:0033686 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of luteinizing hormone secretion(GO:0033686) |
0.1 | 1.6 | GO:0042990 | regulation of transcription factor import into nucleus(GO:0042990) |
0.1 | 8.0 | GO:0007059 | chromosome segregation(GO:0007059) |
0.1 | 0.1 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.1 | 0.9 | GO:0031398 | positive regulation of protein ubiquitination(GO:0031398) |
0.1 | 0.1 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 0.1 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.1 | 0.6 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.6 | GO:0070633 | transepithelial transport(GO:0070633) |
0.1 | 0.1 | GO:0002339 | B cell selection(GO:0002339) |
0.1 | 1.2 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.1 | 0.4 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.1 | 0.4 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.1 | 6.2 | GO:0006310 | DNA recombination(GO:0006310) |
0.1 | 0.6 | GO:0009303 | rRNA transcription(GO:0009303) ncRNA transcription(GO:0098781) |
0.1 | 0.4 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.6 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.7 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.1 | 0.1 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.3 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.1 | 3.8 | GO:0006006 | glucose metabolic process(GO:0006006) |
0.1 | 0.7 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 0.5 | GO:0036344 | platelet morphogenesis(GO:0036344) |
0.1 | 0.3 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.1 | 3.7 | GO:0006397 | mRNA processing(GO:0006397) |
0.1 | 2.8 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.4 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.3 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.1 | 0.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.1 | GO:0032200 | telomere maintenance(GO:0000723) telomere organization(GO:0032200) |
0.1 | 1.0 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.1 | 0.1 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
0.1 | 0.1 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.1 | 0.8 | GO:0072665 | protein localization to vacuole(GO:0072665) |
0.1 | 0.1 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 0.3 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.1 | 0.1 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.1 | 0.1 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.1 | 0.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 0.1 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.1 | 0.4 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.1 | 0.5 | GO:0019395 | fatty acid oxidation(GO:0019395) |
0.1 | 0.6 | GO:0070076 | histone lysine demethylation(GO:0070076) |
0.1 | 0.7 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.1 | 0.5 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.9 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.2 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 1.7 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.1 | 1.6 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.4 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.1 | 1.6 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 1.2 | GO:0071806 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.1 | 0.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.8 | GO:0006352 | DNA-templated transcription, initiation(GO:0006352) |
0.1 | 0.1 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.1 | 4.4 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 0.1 | GO:0016093 | polyprenol metabolic process(GO:0016093) |
0.1 | 0.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 1.2 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.1 | GO:0033604 | negative regulation of catecholamine secretion(GO:0033604) |
0.1 | 2.5 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.1 | 0.4 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.1 | 0.5 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.1 | 0.7 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.1 | 0.2 | GO:1901660 | calcium ion export(GO:1901660) |
0.1 | 0.8 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.1 | 0.1 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) |
0.1 | 0.2 | GO:0060406 | regulation of penile erection(GO:0060405) positive regulation of penile erection(GO:0060406) |
0.1 | 1.3 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.1 | 0.9 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.1 | 0.4 | GO:0019614 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.1 | 0.1 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 1.4 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.1 | GO:0071674 | mononuclear cell migration(GO:0071674) |
0.1 | 1.4 | GO:0007584 | response to nutrient(GO:0007584) |
0.1 | 0.1 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.1 | 0.3 | GO:0071800 | podosome assembly(GO:0071800) |
0.1 | 1.1 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.1 | 0.2 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 0.3 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 0.1 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 15.7 | GO:0006412 | translation(GO:0006412) |
0.1 | 3.6 | GO:1903747 | regulation of establishment of protein localization to mitochondrion(GO:1903747) |
0.1 | 0.1 | GO:0043331 | response to dsRNA(GO:0043331) |
0.1 | 0.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.2 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 0.3 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.3 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.1 | 0.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 0.1 | GO:0045622 | regulation of T-helper cell differentiation(GO:0045622) |
0.1 | 0.5 | GO:0030826 | regulation of cGMP biosynthetic process(GO:0030826) |
0.1 | 0.1 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 0.3 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.1 | 0.1 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.1 | 1.1 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.1 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 0.2 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.1 | 0.4 | GO:1904970 | brush border assembly(GO:1904970) |
0.1 | 0.1 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.1 | 0.3 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.1 | 0.8 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.1 | 1.1 | GO:0006818 | hydrogen transport(GO:0006818) |
0.1 | 0.2 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.1 | 0.2 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.1 | 0.1 | GO:0000959 | mitochondrial RNA metabolic process(GO:0000959) |
0.1 | 0.2 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.1 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.1 | 0.5 | GO:0007379 | segment specification(GO:0007379) |
0.1 | 0.2 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.1 | 0.1 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 1.1 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.2 | GO:1902474 | regulation of protein localization to synapse(GO:1902473) positive regulation of protein localization to synapse(GO:1902474) |
0.1 | 0.2 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.1 | 0.3 | GO:0070175 | positive regulation of enamel mineralization(GO:0070175) |
0.1 | 1.1 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.1 | 0.4 | GO:0002347 | response to tumor cell(GO:0002347) |
0.1 | 0.2 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.2 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.2 | GO:0044275 | cellular carbohydrate catabolic process(GO:0044275) |
0.1 | 0.9 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 1.3 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 0.1 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.1 | 0.2 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.1 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.1 | 0.1 | GO:0051132 | NK T cell activation(GO:0051132) |
0.1 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 0.2 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 0.3 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.1 | 1.5 | GO:0071824 | protein-DNA complex subunit organization(GO:0071824) |
0.1 | 0.1 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.1 | 1.4 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.1 | 0.2 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.1 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.1 | 0.1 | GO:0098930 | axonal transport(GO:0098930) |
0.1 | 0.2 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.1 | 0.1 | GO:0018198 | peptidyl-cysteine modification(GO:0018198) |
0.1 | 0.2 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.1 | 0.1 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.1 | 0.2 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.1 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.1 | 0.1 | GO:0001893 | maternal placenta development(GO:0001893) |
0.1 | 0.1 | GO:0070316 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) |
0.1 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.2 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.1 | 0.1 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.1 | 0.1 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.1 | 0.1 | GO:0006213 | pyrimidine nucleoside metabolic process(GO:0006213) |
0.1 | 0.3 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.1 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.1 | 0.1 | GO:0002294 | CD4-positive, alpha-beta T cell differentiation involved in immune response(GO:0002294) |
0.1 | 0.1 | GO:0048525 | negative regulation of viral process(GO:0048525) |
0.1 | 2.8 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.1 | 0.3 | GO:0001836 | release of cytochrome c from mitochondria(GO:0001836) |
0.1 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.1 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.1 | 0.1 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.1 | 0.1 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 0.1 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.1 | 0.1 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.1 | 0.3 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.1 | 0.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.4 | GO:0046677 | response to antibiotic(GO:0046677) |
0.1 | 1.0 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.1 | 0.7 | GO:0007602 | phototransduction(GO:0007602) |
0.1 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.2 | GO:0019079 | viral genome replication(GO:0019079) |
0.0 | 0.1 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.0 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.0 | 0.0 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 0.0 | GO:0047496 | vesicle transport along microtubule(GO:0047496) |
0.0 | 0.2 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.1 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.2 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.0 | 0.0 | GO:0002667 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.0 | 0.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.0 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.0 | 0.3 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.0 | 0.0 | GO:2000778 | positive regulation of interleukin-6 secretion(GO:2000778) |
0.0 | 0.4 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.2 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.0 | 0.0 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.0 | 0.1 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) |
0.0 | 0.0 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.0 | 0.2 | GO:0071622 | regulation of granulocyte chemotaxis(GO:0071622) |
0.0 | 0.0 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.0 | 0.2 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.1 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.0 | 0.1 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.0 | 0.1 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.0 | 0.2 | GO:0006342 | chromatin silencing(GO:0006342) |
0.0 | 0.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.2 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.0 | 0.0 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.0 | 3.0 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.1 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.0 | 0.1 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 | 0.1 | GO:0002507 | tolerance induction(GO:0002507) |
0.0 | 0.4 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.0 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.0 | 0.3 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
0.0 | 0.0 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.0 | 0.1 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.0 | 0.1 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.0 | 0.1 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.0 | 0.1 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.0 | 0.0 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.0 | 0.2 | GO:0042100 | B cell proliferation(GO:0042100) |
0.0 | 0.1 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.0 | 0.1 | GO:0043043 | peptide biosynthetic process(GO:0043043) |
0.0 | 0.3 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.0 | GO:2000108 | positive regulation of leukocyte apoptotic process(GO:2000108) |
0.0 | 0.1 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
0.0 | 0.0 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.1 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.0 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.0 | 12.8 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.0 | GO:0021557 | oculomotor nerve development(GO:0021557) |
0.0 | 0.0 | GO:0033875 | coenzyme A metabolic process(GO:0015936) nucleoside bisphosphate metabolic process(GO:0033865) ribonucleoside bisphosphate metabolic process(GO:0033875) purine nucleoside bisphosphate metabolic process(GO:0034032) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.7 | 18.6 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
3.6 | 14.3 | GO:1990130 | Iml1 complex(GO:1990130) |
2.8 | 13.8 | GO:0008091 | spectrin(GO:0008091) |
2.6 | 7.8 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
2.6 | 10.4 | GO:0000125 | PCAF complex(GO:0000125) |
2.4 | 17.0 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
2.4 | 9.6 | GO:0071141 | SMAD protein complex(GO:0071141) |
2.4 | 7.1 | GO:0005745 | m-AAA complex(GO:0005745) |
2.1 | 2.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
2.1 | 2.1 | GO:0031523 | Myb complex(GO:0031523) |
2.1 | 6.2 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
2.0 | 5.9 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
2.0 | 11.7 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
1.9 | 9.7 | GO:0033093 | Weibel-Palade body(GO:0033093) |
1.9 | 7.5 | GO:0072487 | MSL complex(GO:0072487) |
1.9 | 20.5 | GO:0030914 | STAGA complex(GO:0030914) |
1.8 | 27.0 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
1.8 | 8.9 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.8 | 7.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
1.8 | 7.0 | GO:0044316 | cone cell pedicle(GO:0044316) |
1.8 | 5.3 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
1.7 | 17.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
1.7 | 5.0 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.6 | 12.9 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
1.6 | 4.8 | GO:0005667 | transcription factor complex(GO:0005667) |
1.6 | 4.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.6 | 6.4 | GO:0005642 | annulate lamellae(GO:0005642) |
1.6 | 6.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
1.6 | 9.3 | GO:0070820 | tertiary granule(GO:0070820) |
1.5 | 13.9 | GO:0005869 | dynactin complex(GO:0005869) |
1.5 | 10.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.5 | 9.0 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
1.5 | 5.8 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.5 | 7.3 | GO:0031298 | replication fork protection complex(GO:0031298) |
1.5 | 1.5 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
1.4 | 5.8 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
1.4 | 4.3 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
1.4 | 2.8 | GO:0071203 | WASH complex(GO:0071203) |
1.4 | 4.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.4 | 1.4 | GO:0016939 | kinesin II complex(GO:0016939) |
1.4 | 6.9 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.3 | 4.0 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
1.3 | 1.3 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
1.3 | 3.9 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
1.3 | 2.6 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
1.3 | 2.6 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
1.3 | 10.4 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
1.3 | 14.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
1.3 | 3.9 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
1.3 | 5.1 | GO:0042583 | chromaffin granule(GO:0042583) |
1.3 | 3.8 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
1.3 | 6.3 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
1.2 | 41.2 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
1.2 | 5.0 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
1.2 | 4.9 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
1.2 | 3.7 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
1.2 | 11.0 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
1.2 | 9.7 | GO:0044232 | organelle membrane contact site(GO:0044232) |
1.2 | 1.2 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
1.2 | 14.5 | GO:0071564 | npBAF complex(GO:0071564) |
1.2 | 4.8 | GO:0033269 | internode region of axon(GO:0033269) |
1.2 | 6.0 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
1.2 | 3.6 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
1.2 | 3.5 | GO:0005833 | hemoglobin complex(GO:0005833) |
1.2 | 8.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
1.2 | 4.6 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
1.2 | 3.5 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
1.1 | 3.4 | GO:0016514 | SWI/SNF complex(GO:0016514) |
1.1 | 11.2 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
1.1 | 3.3 | GO:0097149 | centralspindlin complex(GO:0097149) |
1.1 | 8.8 | GO:0070652 | HAUS complex(GO:0070652) |
1.1 | 3.3 | GO:0097413 | Lewy body(GO:0097413) |
1.1 | 7.7 | GO:0042382 | paraspeckles(GO:0042382) |
1.1 | 7.6 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
1.1 | 7.5 | GO:0031931 | TORC1 complex(GO:0031931) |
1.1 | 7.4 | GO:0070688 | MLL5-L complex(GO:0070688) |
1.0 | 3.1 | GO:0097452 | GAIT complex(GO:0097452) |
1.0 | 4.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
1.0 | 3.1 | GO:0097427 | microtubule bundle(GO:0097427) |
1.0 | 5.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
1.0 | 3.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
1.0 | 7.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
1.0 | 5.1 | GO:0005638 | lamin filament(GO:0005638) |
1.0 | 4.0 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.0 | 4.0 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
1.0 | 10.9 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
1.0 | 5.9 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
1.0 | 13.7 | GO:0000974 | Prp19 complex(GO:0000974) |
1.0 | 3.9 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
1.0 | 13.7 | GO:0001891 | phagocytic cup(GO:0001891) |
1.0 | 9.7 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
1.0 | 2.9 | GO:0097513 | myosin II filament(GO:0097513) |
1.0 | 6.7 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.9 | 5.7 | GO:0001940 | male pronucleus(GO:0001940) |
0.9 | 3.8 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.9 | 5.6 | GO:0098553 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.9 | 3.7 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.9 | 2.8 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.9 | 3.7 | GO:0097542 | ciliary tip(GO:0097542) |
0.9 | 3.7 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.9 | 2.7 | GO:0042585 | germinal vesicle(GO:0042585) |
0.9 | 2.6 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.9 | 2.6 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.9 | 11.2 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.9 | 5.2 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.9 | 12.1 | GO:0031528 | microvillus membrane(GO:0031528) |
0.9 | 1.7 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.9 | 9.4 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.9 | 2.6 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.8 | 2.5 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.8 | 1.7 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.8 | 6.7 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.8 | 5.0 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.8 | 0.8 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.8 | 29.8 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.8 | 6.6 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.8 | 4.9 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.8 | 4.9 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.8 | 2.5 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.8 | 2.4 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.8 | 5.7 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.8 | 2.4 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.8 | 4.0 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.8 | 4.0 | GO:0030870 | Mre11 complex(GO:0030870) |
0.8 | 7.2 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.8 | 0.8 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.8 | 4.8 | GO:0001739 | sex chromatin(GO:0001739) |
0.8 | 4.0 | GO:0005827 | polar microtubule(GO:0005827) |
0.8 | 7.9 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.8 | 8.7 | GO:0031941 | filamentous actin(GO:0031941) |
0.8 | 11.7 | GO:0005682 | U5 snRNP(GO:0005682) |
0.8 | 12.4 | GO:0000145 | exocyst(GO:0000145) |
0.8 | 9.3 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.8 | 2.3 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.8 | 6.1 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.8 | 2.3 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.8 | 11.5 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.8 | 4.6 | GO:0034709 | methylosome(GO:0034709) |
0.8 | 1.5 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.8 | 1.5 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.8 | 3.8 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.8 | 11.4 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.8 | 3.0 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.8 | 9.8 | GO:0005844 | polysome(GO:0005844) |
0.8 | 7.5 | GO:0008278 | cohesin complex(GO:0008278) |
0.7 | 2.2 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.7 | 1.5 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.7 | 5.9 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.7 | 16.8 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.7 | 6.6 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.7 | 41.3 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.7 | 5.8 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.7 | 2.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.7 | 2.2 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) |
0.7 | 14.4 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.7 | 3.6 | GO:0000800 | lateral element(GO:0000800) |
0.7 | 1.4 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.7 | 5.0 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.7 | 0.7 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.7 | 2.1 | GO:0000805 | X chromosome(GO:0000805) |
0.7 | 2.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.7 | 2.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.7 | 23.7 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.7 | 22.3 | GO:0005876 | spindle microtubule(GO:0005876) |
0.7 | 4.8 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.7 | 23.7 | GO:0005776 | autophagosome(GO:0005776) |
0.7 | 1.4 | GO:0032010 | phagolysosome(GO:0032010) |
0.7 | 4.0 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.7 | 2.0 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.7 | 4.0 | GO:0071437 | invadopodium(GO:0071437) |
0.7 | 4.0 | GO:0030008 | TRAPP complex(GO:0030008) |
0.7 | 1.3 | GO:0089701 | U2AF(GO:0089701) |
0.7 | 23.0 | GO:0045171 | intercellular bridge(GO:0045171) |
0.7 | 1.3 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.7 | 4.6 | GO:0016580 | Sin3 complex(GO:0016580) |
0.7 | 2.0 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.7 | 7.8 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.7 | 3.9 | GO:0005796 | Golgi lumen(GO:0005796) |
0.7 | 7.8 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.6 | 4.5 | GO:0001650 | fibrillar center(GO:0001650) |
0.6 | 1.3 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.6 | 61.8 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.6 | 8.3 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.6 | 1.9 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.6 | 3.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.6 | 2.5 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.6 | 1.9 | GO:0033646 | host cell cytoplasm(GO:0030430) host intracellular part(GO:0033646) host cell cytoplasm part(GO:0033655) intracellular region of host(GO:0043656) |
0.6 | 2.5 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.6 | 2.5 | GO:0045298 | tubulin complex(GO:0045298) |
0.6 | 2.5 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.6 | 1.3 | GO:0045120 | pronucleus(GO:0045120) |
0.6 | 9.4 | GO:0000242 | pericentriolar material(GO:0000242) |
0.6 | 3.8 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.6 | 1.2 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.6 | 3.7 | GO:0071986 | Ragulator complex(GO:0071986) |
0.6 | 8.5 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.6 | 6.7 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.6 | 6.7 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.6 | 6.7 | GO:0032039 | integrator complex(GO:0032039) |
0.6 | 1.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.6 | 3.0 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.6 | 3.6 | GO:0005652 | nuclear lamina(GO:0005652) |
0.6 | 5.4 | GO:0097346 | Ino80 complex(GO:0031011) INO80-type complex(GO:0097346) |
0.6 | 4.8 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.6 | 3.0 | GO:0042587 | glycogen granule(GO:0042587) |
0.6 | 25.7 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.6 | 1.8 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.6 | 1.2 | GO:0001939 | female pronucleus(GO:0001939) |
0.6 | 4.2 | GO:0000812 | Swr1 complex(GO:0000812) |
0.6 | 1.2 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.6 | 5.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.6 | 1.2 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.6 | 4.1 | GO:0010008 | endosome membrane(GO:0010008) |
0.6 | 39.7 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.6 | 2.9 | GO:0044215 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.6 | 2.3 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.6 | 19.3 | GO:0016592 | mediator complex(GO:0016592) |
0.6 | 1.1 | GO:0033263 | CORVET complex(GO:0033263) |
0.6 | 1.1 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.6 | 2.8 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.6 | 1.7 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.6 | 3.3 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.5 | 4.4 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.5 | 22.4 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.5 | 3.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.5 | 16.8 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.5 | 3.2 | GO:0034464 | BBSome(GO:0034464) |
0.5 | 13.0 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.5 | 21.5 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.5 | 4.3 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.5 | 7.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.5 | 3.7 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.5 | 1.1 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.5 | 3.2 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.5 | 4.2 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.5 | 5.8 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.5 | 1.6 | GO:0097255 | R2TP complex(GO:0097255) |
0.5 | 1.6 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.5 | 1.6 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.5 | 11.4 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.5 | 4.6 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.5 | 4.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.5 | 1.0 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.5 | 2.6 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.5 | 6.6 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.5 | 2.5 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.5 | 10.6 | GO:0031901 | early endosome membrane(GO:0031901) |
0.5 | 1.5 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.5 | 9.6 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.5 | 3.0 | GO:0031415 | NatA complex(GO:0031415) |
0.5 | 8.9 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.5 | 2.5 | GO:0090544 | BAF-type complex(GO:0090544) |
0.5 | 21.2 | GO:0016363 | nuclear matrix(GO:0016363) |
0.5 | 3.0 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.5 | 4.4 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.5 | 21.1 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.5 | 2.4 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.5 | 1.0 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.5 | 2.4 | GO:0061617 | MICOS complex(GO:0061617) |
0.5 | 2.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.5 | 1.9 | GO:0000796 | condensin complex(GO:0000796) |
0.5 | 21.1 | GO:0016605 | PML body(GO:0016605) |
0.5 | 140.7 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.5 | 20.6 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.5 | 11.0 | GO:0001772 | immunological synapse(GO:0001772) |
0.5 | 1.4 | GO:0070876 | SOSS complex(GO:0070876) |
0.5 | 4.7 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.5 | 10.4 | GO:0097228 | sperm principal piece(GO:0097228) |
0.5 | 5.2 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.5 | 1.4 | GO:0036396 | MIS complex(GO:0036396) |
0.5 | 5.1 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.5 | 1.4 | GO:0005955 | calcineurin complex(GO:0005955) |
0.5 | 1.4 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.5 | 8.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.5 | 6.0 | GO:0097440 | apical dendrite(GO:0097440) |
0.5 | 4.6 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.5 | 18.0 | GO:0000502 | proteasome complex(GO:0000502) |
0.4 | 1.8 | GO:0000938 | GARP complex(GO:0000938) |
0.4 | 5.4 | GO:0031519 | PcG protein complex(GO:0031519) |
0.4 | 2.2 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.4 | 6.7 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.4 | 0.4 | GO:0042827 | platelet dense granule(GO:0042827) |
0.4 | 3.0 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.4 | 1.7 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.4 | 5.2 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.4 | 3.9 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.4 | 4.7 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.4 | 32.6 | GO:0072562 | blood microparticle(GO:0072562) |
0.4 | 0.4 | GO:0005686 | U2 snRNP(GO:0005686) |
0.4 | 49.8 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.4 | 2.1 | GO:0070938 | contractile ring(GO:0070938) |
0.4 | 0.4 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.4 | 1.3 | GO:0072687 | meiotic spindle(GO:0072687) |
0.4 | 15.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.4 | 2.5 | GO:0016600 | flotillin complex(GO:0016600) |
0.4 | 1.6 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.4 | 1.2 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.4 | 21.8 | GO:0005795 | Golgi stack(GO:0005795) |
0.4 | 4.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.4 | 0.4 | GO:0000811 | GINS complex(GO:0000811) |
0.4 | 2.8 | GO:0016272 | prefoldin complex(GO:0016272) |
0.4 | 1.2 | GO:0070695 | FHF complex(GO:0070695) |
0.4 | 4.8 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.4 | 23.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.4 | 3.5 | GO:0002102 | podosome(GO:0002102) |
0.4 | 11.7 | GO:0005811 | lipid particle(GO:0005811) |
0.4 | 3.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.4 | 0.4 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.4 | 24.6 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.4 | 1.1 | GO:0043203 | axon hillock(GO:0043203) |
0.4 | 32.4 | GO:0016604 | nuclear body(GO:0016604) |
0.4 | 0.4 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.4 | 3.8 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.4 | 1.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.4 | 1.9 | GO:0000346 | transcription export complex(GO:0000346) |
0.4 | 1.9 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.4 | 0.4 | GO:1990745 | EARP complex(GO:1990745) |
0.4 | 11.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.4 | 0.4 | GO:0061574 | ASAP complex(GO:0061574) |
0.4 | 1.1 | GO:0005914 | spot adherens junction(GO:0005914) |
0.4 | 12.5 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.4 | 7.7 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.4 | 11.0 | GO:0022627 | small ribosomal subunit(GO:0015935) cytosolic small ribosomal subunit(GO:0022627) |
0.4 | 1.8 | GO:0000801 | central element(GO:0000801) |
0.4 | 19.1 | GO:0005814 | centriole(GO:0005814) |
0.4 | 1.1 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.4 | 0.4 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.4 | 1.8 | GO:0042581 | specific granule(GO:0042581) |
0.4 | 0.4 | GO:0001652 | granular component(GO:0001652) |
0.3 | 2.8 | GO:0044439 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.3 | 1.7 | GO:0031248 | protein acetyltransferase complex(GO:0031248) N-terminal protein acetyltransferase complex(GO:0031414) acetyltransferase complex(GO:1902493) |
0.3 | 0.7 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.3 | 0.7 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.3 | 2.7 | GO:0030894 | replisome(GO:0030894) |
0.3 | 1.4 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.3 | 1.4 | GO:0002177 | manchette(GO:0002177) |
0.3 | 5.7 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.3 | 354.5 | GO:0005654 | nucleoplasm(GO:0005654) |
0.3 | 4.6 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.3 | 5.6 | GO:0005771 | multivesicular body(GO:0005771) |
0.3 | 2.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.3 | 2.9 | GO:0000786 | nucleosome(GO:0000786) |
0.3 | 0.3 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.3 | 0.9 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.3 | 0.9 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.3 | 1.3 | GO:0031512 | motile primary cilium(GO:0031512) |
0.3 | 10.6 | GO:0036064 | ciliary basal body(GO:0036064) |
0.3 | 6.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.3 | 0.9 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.3 | 0.3 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.3 | 3.3 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.3 | 0.3 | GO:0071817 | MMXD complex(GO:0071817) |
0.3 | 1.2 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
0.3 | 82.7 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.3 | 1.8 | GO:0032982 | myosin filament(GO:0032982) |
0.3 | 0.9 | GO:0031045 | dense core granule(GO:0031045) |
0.3 | 0.6 | GO:0044327 | dendritic spine head(GO:0044327) |
0.3 | 2.0 | GO:0000792 | heterochromatin(GO:0000792) |
0.3 | 0.8 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.3 | 1.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.3 | 0.6 | GO:0005579 | membrane attack complex(GO:0005579) |
0.3 | 0.6 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.3 | 0.8 | GO:0030056 | hemidesmosome(GO:0030056) |
0.3 | 0.8 | GO:0071439 | clathrin complex(GO:0071439) |
0.3 | 6.2 | GO:0030684 | preribosome(GO:0030684) |
0.3 | 0.3 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.3 | 36.4 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.3 | 1.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 3.0 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.3 | 185.9 | GO:0005739 | mitochondrion(GO:0005739) |
0.3 | 1.5 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 0.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.2 | 1.5 | GO:0034399 | nuclear periphery(GO:0034399) |
0.2 | 1.0 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 5.4 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.2 | 0.7 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.2 | 1.0 | GO:0031082 | BLOC complex(GO:0031082) |
0.2 | 0.5 | GO:1990391 | DNA repair complex(GO:1990391) |
0.2 | 0.5 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.2 | 1.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 5.5 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.2 | 0.2 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.2 | 8.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.2 | 0.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.2 | 0.7 | GO:0045179 | apical cortex(GO:0045179) |
0.2 | 0.9 | GO:0036128 | CatSper complex(GO:0036128) |
0.2 | 1.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.2 | 1.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 0.6 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 2.1 | GO:0016460 | myosin II complex(GO:0016460) |
0.2 | 0.4 | GO:0030118 | clathrin coat(GO:0030118) |
0.2 | 1.0 | GO:0071546 | pi-body(GO:0071546) |
0.2 | 0.4 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.2 | 46.2 | GO:0005730 | nucleolus(GO:0005730) |
0.2 | 0.6 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 0.6 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.2 | 0.2 | GO:0030120 | vesicle coat(GO:0030120) |
0.2 | 29.3 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.2 | 0.8 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.2 | 0.2 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.2 | 1.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 1.7 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 0.4 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.2 | 0.6 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.2 | 0.2 | GO:0002141 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) USH2 complex(GO:1990696) |
0.2 | 0.6 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 1.5 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.2 | 4.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.2 | 0.7 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.2 | 0.4 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.2 | 0.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 0.7 | GO:0072686 | mitotic spindle(GO:0072686) |
0.2 | 3.4 | GO:0030658 | transport vesicle membrane(GO:0030658) |
0.2 | 0.5 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.2 | 3.5 | GO:0005938 | cell cortex(GO:0005938) |
0.2 | 0.2 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.2 | 0.3 | GO:0097443 | sorting endosome(GO:0097443) |
0.2 | 0.5 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.2 | 0.5 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.2 | 0.5 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 18.3 | GO:0005694 | chromosome(GO:0005694) |
0.2 | 1.4 | GO:0032587 | ruffle membrane(GO:0032587) |
0.2 | 0.5 | GO:0051233 | spindle midzone(GO:0051233) |
0.2 | 1.7 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.1 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.1 | 0.4 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.1 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 1.2 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 1.0 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 2.6 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 5.1 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 4.1 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 2.7 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 2.9 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 2.8 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 73.4 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 0.8 | GO:0005819 | spindle(GO:0005819) |
0.1 | 0.4 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 0.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 2.3 | GO:0030659 | cytoplasmic vesicle membrane(GO:0030659) |
0.1 | 0.4 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 1.0 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 2.7 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 50.9 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 0.8 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 0.5 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.6 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.1 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.1 | 0.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 0.3 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.0 | 0.1 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.0 | 4.7 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 49.0 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 0.6 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.0 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 43.7 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.0 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.1 | 24.5 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
6.1 | 18.2 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
4.9 | 19.4 | GO:0009374 | biotin binding(GO:0009374) |
4.3 | 13.0 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
4.3 | 17.1 | GO:0031720 | haptoglobin binding(GO:0031720) |
3.8 | 3.8 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
3.2 | 22.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
3.1 | 6.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
3.0 | 11.9 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
2.9 | 8.7 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
2.9 | 11.5 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
2.9 | 8.6 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
2.8 | 8.4 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
2.6 | 7.8 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
2.3 | 7.0 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
2.3 | 13.9 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
2.2 | 8.8 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
2.2 | 6.6 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
2.2 | 6.6 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
2.2 | 6.5 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
2.1 | 8.6 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
2.1 | 8.5 | GO:0004849 | uridine kinase activity(GO:0004849) |
2.1 | 8.5 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
2.1 | 6.3 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
2.1 | 8.4 | GO:0032564 | dATP binding(GO:0032564) |
2.1 | 4.2 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
2.1 | 6.2 | GO:0004104 | cholinesterase activity(GO:0004104) |
2.1 | 6.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
2.0 | 6.0 | GO:0030620 | U2 snRNA binding(GO:0030620) |
2.0 | 4.0 | GO:0004103 | choline kinase activity(GO:0004103) |
2.0 | 7.9 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
2.0 | 5.9 | GO:0000339 | RNA cap binding(GO:0000339) |
2.0 | 11.8 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
2.0 | 5.9 | GO:0030350 | iron-responsive element binding(GO:0030350) |
1.9 | 15.3 | GO:1990405 | protein antigen binding(GO:1990405) |
1.9 | 5.6 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
1.8 | 5.5 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
1.8 | 7.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
1.8 | 10.8 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
1.8 | 1.8 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.8 | 5.3 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
1.7 | 3.4 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
1.7 | 5.2 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
1.7 | 1.7 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
1.7 | 1.7 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
1.7 | 5.0 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
1.7 | 6.6 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
1.6 | 14.7 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
1.6 | 4.8 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
1.6 | 6.4 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
1.6 | 12.7 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
1.6 | 6.3 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
1.6 | 1.6 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
1.6 | 4.7 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.6 | 4.7 | GO:0004064 | arylesterase activity(GO:0004064) |
1.6 | 10.9 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.5 | 6.2 | GO:0015232 | heme transporter activity(GO:0015232) |
1.5 | 7.6 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
1.5 | 4.6 | GO:1990239 | steroid hormone binding(GO:1990239) |
1.5 | 12.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.5 | 15.0 | GO:0008432 | JUN kinase binding(GO:0008432) |
1.5 | 4.4 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
1.5 | 5.9 | GO:0042731 | PH domain binding(GO:0042731) |
1.4 | 10.1 | GO:0034046 | poly(G) binding(GO:0034046) |
1.4 | 4.3 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
1.4 | 5.7 | GO:0002060 | purine nucleobase binding(GO:0002060) |
1.4 | 4.2 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
1.4 | 4.2 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
1.4 | 4.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
1.4 | 6.8 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
1.4 | 4.1 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
1.4 | 6.8 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
1.4 | 5.4 | GO:0038100 | nodal binding(GO:0038100) |
1.3 | 6.7 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
1.3 | 4.0 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
1.3 | 11.9 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
1.3 | 6.6 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
1.3 | 9.1 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
1.3 | 11.7 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
1.3 | 1.3 | GO:0030984 | kininogen binding(GO:0030984) |
1.3 | 9.1 | GO:0019957 | C-C chemokine binding(GO:0019957) |
1.3 | 3.8 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
1.3 | 3.8 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
1.3 | 8.9 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
1.3 | 3.8 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.3 | 3.8 | GO:0019770 | IgG receptor activity(GO:0019770) |
1.3 | 3.8 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
1.3 | 6.3 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
1.2 | 3.7 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.2 | 3.7 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
1.2 | 7.4 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
1.2 | 3.7 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
1.2 | 3.7 | GO:1990188 | euchromatin binding(GO:1990188) |
1.2 | 6.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
1.2 | 2.4 | GO:0004017 | adenylate kinase activity(GO:0004017) |
1.2 | 4.8 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
1.2 | 4.7 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
1.2 | 5.9 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
1.2 | 5.9 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
1.2 | 7.0 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
1.2 | 3.5 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
1.2 | 3.5 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
1.2 | 2.3 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
1.2 | 3.5 | GO:0050692 | DBD domain binding(GO:0050692) |
1.1 | 16.1 | GO:0035173 | histone kinase activity(GO:0035173) |
1.1 | 4.6 | GO:0005047 | signal recognition particle binding(GO:0005047) |
1.1 | 28.3 | GO:0045502 | dynein binding(GO:0045502) |
1.1 | 4.5 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
1.1 | 4.5 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
1.1 | 16.9 | GO:0005521 | lamin binding(GO:0005521) |
1.1 | 3.4 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
1.1 | 4.5 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
1.1 | 4.5 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
1.1 | 3.4 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
1.1 | 3.3 | GO:0004771 | sterol esterase activity(GO:0004771) |
1.1 | 2.2 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
1.1 | 4.3 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
1.1 | 3.3 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
1.1 | 5.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
1.1 | 42.1 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
1.1 | 8.6 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
1.1 | 9.6 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
1.1 | 18.0 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
1.1 | 8.5 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
1.1 | 5.3 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
1.1 | 7.4 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
1.1 | 20.0 | GO:0001848 | complement binding(GO:0001848) |
1.1 | 49.5 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
1.0 | 19.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
1.0 | 3.1 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
1.0 | 1.0 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
1.0 | 18.9 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
1.0 | 3.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
1.0 | 10.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
1.0 | 10.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
1.0 | 6.2 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
1.0 | 1.0 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
1.0 | 8.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
1.0 | 4.1 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
1.0 | 13.3 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
1.0 | 5.1 | GO:0070061 | fructose binding(GO:0070061) |
1.0 | 6.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
1.0 | 3.0 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
1.0 | 1.0 | GO:0016414 | O-octanoyltransferase activity(GO:0016414) |
1.0 | 3.0 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
1.0 | 11.0 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
1.0 | 4.0 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
1.0 | 10.0 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
1.0 | 4.0 | GO:0070410 | co-SMAD binding(GO:0070410) |
1.0 | 2.0 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
1.0 | 3.0 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
1.0 | 5.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
1.0 | 2.9 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
1.0 | 8.8 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
1.0 | 10.7 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
1.0 | 8.7 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
1.0 | 3.9 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
1.0 | 7.7 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
1.0 | 3.8 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
1.0 | 4.8 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
1.0 | 3.8 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
1.0 | 1.0 | GO:0070538 | oleic acid binding(GO:0070538) |
0.9 | 2.8 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.9 | 10.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.9 | 0.9 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.9 | 8.3 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.9 | 2.8 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.9 | 3.7 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.9 | 7.3 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.9 | 2.7 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.9 | 1.8 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.9 | 2.7 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.9 | 10.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.9 | 4.5 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.9 | 4.5 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.9 | 14.3 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.9 | 2.7 | GO:0051425 | PTB domain binding(GO:0051425) |
0.9 | 4.4 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.9 | 2.7 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.9 | 24.0 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.9 | 4.4 | GO:0052813 | phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.9 | 8.8 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.9 | 1.8 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.9 | 1.8 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.9 | 5.3 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.9 | 2.6 | GO:0036033 | mediator complex binding(GO:0036033) |
0.9 | 10.5 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.9 | 0.9 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.9 | 13.0 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.9 | 0.9 | GO:0016428 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.9 | 11.3 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.9 | 4.3 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.9 | 1.7 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.9 | 2.6 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.9 | 7.7 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.9 | 9.4 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.8 | 8.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.8 | 23.4 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.8 | 21.7 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.8 | 3.3 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.8 | 2.5 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.8 | 5.0 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.8 | 7.4 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.8 | 17.4 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.8 | 2.5 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.8 | 1.6 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.8 | 6.6 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.8 | 13.1 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.8 | 3.3 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.8 | 4.0 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.8 | 2.4 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.8 | 5.6 | GO:0050700 | CARD domain binding(GO:0050700) |
0.8 | 4.8 | GO:0008494 | translation activator activity(GO:0008494) |
0.8 | 11.1 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.8 | 3.2 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.8 | 2.4 | GO:0030911 | TPR domain binding(GO:0030911) |
0.8 | 9.5 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.8 | 7.9 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.8 | 1.6 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.8 | 3.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.8 | 0.8 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.8 | 14.2 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.8 | 2.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.8 | 2.3 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.8 | 5.5 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.8 | 3.1 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.8 | 14.8 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.8 | 10.9 | GO:0019825 | oxygen binding(GO:0019825) |
0.8 | 1.6 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.8 | 21.7 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.8 | 21.7 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.8 | 0.8 | GO:0045340 | mercury ion binding(GO:0045340) |
0.8 | 3.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.8 | 1.5 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.8 | 3.8 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.8 | 1.5 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.8 | 2.3 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.8 | 4.6 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.8 | 0.8 | GO:0008142 | oxysterol binding(GO:0008142) |
0.8 | 0.8 | GO:0015651 | organic cation transmembrane transporter activity(GO:0015101) quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.8 | 0.8 | GO:0035870 | dITP diphosphatase activity(GO:0035870) |
0.8 | 1.5 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.7 | 0.7 | GO:0043426 | MRF binding(GO:0043426) |
0.7 | 23.2 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.7 | 1.5 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.7 | 0.7 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.7 | 11.2 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.7 | 10.4 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.7 | 2.2 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.7 | 2.9 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.7 | 2.9 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.7 | 13.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.7 | 15.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.7 | 5.1 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.7 | 0.7 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.7 | 0.7 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.7 | 3.6 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.7 | 6.4 | GO:0031386 | protein tag(GO:0031386) |
0.7 | 2.1 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.7 | 4.3 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.7 | 2.8 | GO:0043559 | insulin binding(GO:0043559) |
0.7 | 0.7 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) |
0.7 | 0.7 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.7 | 1.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.7 | 2.8 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.7 | 6.3 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.7 | 2.8 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.7 | 1.4 | GO:0035877 | death effector domain binding(GO:0035877) |
0.7 | 4.2 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.7 | 3.5 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.7 | 0.7 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.7 | 9.0 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.7 | 6.2 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.7 | 2.7 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.7 | 2.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.7 | 1.4 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.7 | 0.7 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.7 | 0.7 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.7 | 2.7 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.7 | 3.4 | GO:0035473 | lipase binding(GO:0035473) |
0.7 | 19.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.7 | 2.7 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.7 | 1.3 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.7 | 4.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.7 | 1.3 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.7 | 1.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.7 | 12.4 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.6 | 8.4 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.6 | 1.9 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.6 | 0.6 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.6 | 0.6 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.6 | 17.3 | GO:0034792 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.6 | 1.3 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.6 | 5.7 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.6 | 1.3 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.6 | 1.9 | GO:0010181 | FMN binding(GO:0010181) |
0.6 | 1.3 | GO:0019961 | interferon binding(GO:0019961) |
0.6 | 4.4 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.6 | 1.2 | GO:0016151 | nickel cation binding(GO:0016151) |
0.6 | 6.8 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.6 | 1.8 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.6 | 3.7 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.6 | 4.3 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.6 | 3.7 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.6 | 1.2 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.6 | 4.9 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.6 | 2.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.6 | 2.4 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.6 | 4.2 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.6 | 1.8 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.6 | 4.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.6 | 0.6 | GO:0050693 | LBD domain binding(GO:0050693) |
0.6 | 9.0 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.6 | 4.8 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.6 | 7.1 | GO:0001618 | virus receptor activity(GO:0001618) |
0.6 | 0.6 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.6 | 14.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.6 | 6.5 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.6 | 4.1 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.6 | 17.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.6 | 1.8 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.6 | 0.6 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.6 | 0.6 | GO:0052744 | phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.6 | 2.9 | GO:0031013 | troponin I binding(GO:0031013) |
0.6 | 5.7 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.6 | 1.7 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
0.6 | 5.1 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.6 | 18.3 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.6 | 2.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.6 | 5.7 | GO:0030955 | potassium ion binding(GO:0030955) |
0.6 | 5.6 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.6 | 3.4 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.6 | 0.6 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.6 | 3.3 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.6 | 6.1 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.6 | 2.2 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.6 | 28.2 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.6 | 13.3 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.6 | 1.1 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.6 | 1.7 | GO:0043515 | kinetochore binding(GO:0043515) |
0.5 | 2.7 | GO:0031491 | nucleosome binding(GO:0031491) |
0.5 | 5.5 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.5 | 10.9 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.5 | 1.1 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.5 | 1.1 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.5 | 4.9 | GO:0043531 | ADP binding(GO:0043531) |
0.5 | 2.2 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.5 | 1.6 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.5 | 11.3 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.5 | 3.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.5 | 4.3 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.5 | 1.1 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.5 | 0.5 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.5 | 6.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.5 | 3.7 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.5 | 1.6 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.5 | 2.1 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.5 | 2.6 | GO:0070728 | leucine binding(GO:0070728) |
0.5 | 14.8 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.5 | 5.3 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.5 | 1.1 | GO:0015928 | fucosidase activity(GO:0015928) |
0.5 | 9.4 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.5 | 2.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.5 | 3.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.5 | 5.7 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.5 | 1.0 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.5 | 7.2 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.5 | 8.2 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.5 | 2.0 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.5 | 19.9 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.5 | 3.1 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.5 | 3.6 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.5 | 3.0 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.5 | 17.8 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.5 | 1.0 | GO:0050733 | RS domain binding(GO:0050733) |
0.5 | 2.5 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.5 | 11.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.5 | 1.5 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.5 | 2.5 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.5 | 14.0 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.5 | 3.0 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.5 | 5.9 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.5 | 1.5 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.5 | 3.5 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.5 | 4.4 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.5 | 2.5 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.5 | 1.5 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.5 | 0.5 | GO:0016876 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.5 | 2.4 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.5 | 20.5 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.5 | 3.4 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.5 | 1.4 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.5 | 1.4 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.5 | 3.4 | GO:0034802 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.5 | 12.4 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.5 | 1.9 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.5 | 1.4 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.5 | 5.2 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.5 | 13.2 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.5 | 1.4 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.5 | 1.4 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.5 | 1.4 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.5 | 59.0 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
0.5 | 2.3 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.5 | 4.1 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.5 | 2.7 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.5 | 1.4 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.5 | 1.4 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.5 | 1.4 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.5 | 1.8 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.5 | 0.5 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.4 | 1.3 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.4 | 0.4 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.4 | 1.8 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.4 | 0.9 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.4 | 1.8 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.4 | 3.1 | GO:0080011 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.4 | 4.0 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.4 | 2.2 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.4 | 1.7 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.4 | 1.3 | GO:0043199 | sulfate binding(GO:0043199) |
0.4 | 0.4 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.4 | 0.4 | GO:0016015 | morphogen activity(GO:0016015) |
0.4 | 1.3 | GO:0030957 | Tat protein binding(GO:0030957) |
0.4 | 3.5 | GO:0034871 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.4 | 39.0 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.4 | 1.3 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.4 | 1.3 | GO:0030515 | snoRNA binding(GO:0030515) |
0.4 | 0.9 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.4 | 3.0 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.4 | 4.2 | GO:0015266 | protein channel activity(GO:0015266) |
0.4 | 0.4 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.4 | 0.8 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.4 | 2.9 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.4 | 1.7 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.4 | 0.8 | GO:2001069 | glycogen binding(GO:2001069) |
0.4 | 1.3 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) sugar-phosphatase activity(GO:0050308) |
0.4 | 1.7 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.4 | 3.3 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.4 | 0.8 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.4 | 4.1 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.4 | 0.4 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
0.4 | 8.7 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.4 | 21.4 | GO:0008186 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.4 | 12.2 | GO:0051087 | chaperone binding(GO:0051087) |
0.4 | 1.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.4 | 0.4 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.4 | 0.8 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.4 | 1.6 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.4 | 1.6 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.4 | 2.4 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.4 | 3.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.4 | 3.6 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.4 | 0.4 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.4 | 2.4 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.4 | 16.3 | GO:0019843 | rRNA binding(GO:0019843) |
0.4 | 5.2 | GO:0030145 | manganese ion binding(GO:0030145) |
0.4 | 2.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.4 | 13.4 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.4 | 1.2 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.4 | 1.6 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.4 | 1.9 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.4 | 12.0 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.4 | 0.8 | GO:0034618 | arginine binding(GO:0034618) |
0.4 | 3.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.4 | 1.2 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.4 | 1.6 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.4 | 1.5 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.4 | 1.5 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.4 | 5.8 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.4 | 1.2 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.4 | 1.9 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.4 | 17.2 | GO:0019003 | GDP binding(GO:0019003) |
0.4 | 0.4 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.4 | 2.3 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.4 | 0.4 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.4 | 7.3 | GO:0000049 | tRNA binding(GO:0000049) |
0.4 | 3.4 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.4 | 0.8 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.4 | 0.8 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.4 | 13.3 | GO:0008565 | protein transporter activity(GO:0008565) |
0.4 | 1.5 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.4 | 6.0 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.4 | 7.5 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.4 | 6.4 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.4 | 1.1 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.4 | 58.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.4 | 0.7 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.4 | 3.4 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.4 | 1.5 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.4 | 0.7 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.4 | 0.7 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.4 | 1.8 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.4 | 3.7 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.4 | 7.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.4 | 1.1 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.4 | 1.5 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.4 | 16.7 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.4 | 27.5 | GO:0042393 | histone binding(GO:0042393) |
0.4 | 0.7 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.4 | 1.1 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.4 | 0.7 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.4 | 12.5 | GO:0051117 | ATPase binding(GO:0051117) |
0.4 | 21.7 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.4 | 1.1 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.4 | 3.2 | GO:0043022 | ribosome binding(GO:0043022) |
0.4 | 3.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.4 | 1.1 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.4 | 0.7 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.3 | 1.7 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.3 | 1.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.3 | 1.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.3 | 2.8 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.3 | 0.3 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.3 | 2.0 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.3 | 1.0 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.3 | 8.1 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.3 | 2.7 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.3 | 1.0 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.3 | 0.3 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.3 | 1.7 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.3 | 2.0 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.3 | 1.0 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.3 | 3.0 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.3 | 200.7 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.3 | 1.6 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.3 | 0.6 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.3 | 3.2 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.3 | 1.0 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.3 | 4.7 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.3 | 6.6 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.3 | 1.2 | GO:0032183 | SUMO binding(GO:0032183) |
0.3 | 5.0 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.3 | 9.3 | GO:0004519 | endonuclease activity(GO:0004519) |
0.3 | 9.5 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.3 | 7.3 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.3 | 0.9 | GO:0004359 | glutaminase activity(GO:0004359) |
0.3 | 5.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.3 | 1.2 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.3 | 2.4 | GO:0090484 | drug transporter activity(GO:0090484) |
0.3 | 3.5 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.3 | 4.1 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.3 | 1.7 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.3 | 0.3 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.3 | 2.6 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.3 | 4.9 | GO:0030552 | cAMP binding(GO:0030552) |
0.3 | 0.6 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.3 | 2.8 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.3 | 6.1 | GO:0001047 | core promoter binding(GO:0001047) |
0.3 | 2.2 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.3 | 2.8 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.3 | 0.3 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.3 | 1.1 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.3 | 1.9 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.3 | 1.9 | GO:0031996 | thioesterase binding(GO:0031996) |
0.3 | 4.8 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.3 | 0.5 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.3 | 0.8 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.3 | 0.5 | GO:2001070 | starch binding(GO:2001070) |
0.3 | 1.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.3 | 0.8 | GO:0005534 | galactose binding(GO:0005534) |
0.3 | 1.0 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.3 | 2.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.3 | 2.8 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.3 | 0.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.3 | 8.3 | GO:0005507 | copper ion binding(GO:0005507) |
0.3 | 1.5 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.2 | 2.5 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 1.0 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.2 | 1.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.2 | 0.2 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.2 | 1.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.2 | 0.7 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.2 | 0.7 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.2 | 6.5 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.2 | 5.0 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.2 | 1.2 | GO:0052742 | phosphatidylinositol kinase activity(GO:0052742) |
0.2 | 0.5 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.2 | 0.9 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.2 | 0.9 | GO:0005536 | glucose binding(GO:0005536) |
0.2 | 0.2 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.2 | 0.7 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.2 | 0.7 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.2 | 0.5 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.2 | 1.8 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.2 | 6.1 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.2 | 0.5 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.2 | 0.2 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.2 | 2.9 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.2 | 0.4 | GO:0097617 | annealing activity(GO:0097617) |
0.2 | 0.7 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.2 | 5.1 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 1.3 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.2 | 0.9 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.2 | 0.2 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.2 | 12.7 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.2 | 0.7 | GO:0097016 | L27 domain binding(GO:0097016) |
0.2 | 0.9 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.2 | 1.5 | GO:0019239 | deaminase activity(GO:0019239) |
0.2 | 7.7 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.2 | 0.6 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.2 | 0.6 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.2 | 4.4 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
0.2 | 0.6 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.2 | 0.8 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.2 | 0.2 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.2 | 0.6 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 0.6 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.2 | 1.1 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.2 | 0.6 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 1.3 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.2 | 1.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.2 | 1.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 0.2 | GO:0019002 | GMP binding(GO:0019002) |
0.2 | 0.4 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.2 | 0.6 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.2 | 1.5 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.2 | 3.3 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.2 | 0.2 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.2 | 2.2 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.2 | 30.9 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.2 | 0.2 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.2 | 0.7 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.2 | 6.8 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.2 | 0.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.2 | 0.4 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.2 | 0.4 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.2 | 0.3 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.2 | 12.4 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.2 | 1.0 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.2 | 1.0 | GO:0070628 | proteasome binding(GO:0070628) |
0.2 | 0.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 2.2 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.2 | 0.5 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.2 | 7.6 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.2 | 0.5 | GO:0032451 | demethylase activity(GO:0032451) |
0.2 | 0.3 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.2 | 1.0 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 1.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 0.2 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.2 | 0.8 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 0.3 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.2 | 0.6 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 0.3 | GO:0019808 | polyamine binding(GO:0019808) |
0.2 | 3.4 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.2 | 1.7 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.2 | 0.3 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 13.1 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 5.3 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.6 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.3 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 0.7 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 3.5 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 0.4 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 0.3 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 11.7 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 15.0 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 5.1 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.4 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 0.7 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.1 | 0.8 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 1.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.3 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 1.6 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 0.4 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.9 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 1.0 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 4.5 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 0.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 1.8 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.5 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 0.6 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 0.6 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.1 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.3 | GO:0070815 | procollagen-lysine 5-dioxygenase activity(GO:0008475) peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 12.8 | GO:0004175 | endopeptidase activity(GO:0004175) |
0.1 | 2.5 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.3 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.1 | 0.9 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 1.8 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 1.1 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 1.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.5 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.5 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 0.7 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.1 | 0.7 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 0.4 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 2.7 | GO:0035326 | enhancer binding(GO:0035326) |
0.1 | 0.1 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.1 | 0.1 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.1 | 10.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.7 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.5 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.1 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.1 | 0.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 0.7 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 0.3 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 0.3 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 0.1 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.1 | 0.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.5 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 0.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 2.1 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.1 | 0.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.1 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 1.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.1 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.1 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 8.8 | GO:0003723 | RNA binding(GO:0003723) |
0.1 | 0.1 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.1 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 0.7 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.1 | 1.9 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.1 | GO:0051870 | methotrexate binding(GO:0051870) |
0.1 | 0.4 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.1 | 0.1 | GO:0016741 | transferase activity, transferring one-carbon groups(GO:0016741) |
0.1 | 0.3 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 1.1 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.1 | GO:1901677 | phosphate transmembrane transporter activity(GO:1901677) |
0.1 | 0.4 | GO:0019213 | deacetylase activity(GO:0019213) |
0.1 | 1.6 | GO:0019209 | kinase activator activity(GO:0019209) |
0.1 | 5.4 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.1 | 0.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.3 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.3 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.0 | 4.5 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 4.3 | GO:0008134 | transcription factor binding(GO:0008134) |
0.0 | 0.5 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.1 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.0 | 0.6 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.0 | 3.1 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 0.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.0 | 0.6 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.1 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.5 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.2 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.1 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 0.1 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.4 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.0 | 2.3 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.0 | 0.1 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.1 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.0 | 26.7 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.0 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.1 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.0 | 0.4 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.9 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.1 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.0 | 0.0 | GO:0023023 | MHC protein complex binding(GO:0023023) |
0.0 | 0.0 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.1 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.1 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.0 | 0.2 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.0 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.9 | GO:0005496 | steroid binding(GO:0005496) |
0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.0 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.0 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.0 | 0.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.0 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 5.4 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
1.5 | 8.9 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
1.4 | 1.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
1.4 | 20.6 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
1.4 | 13.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
1.4 | 8.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
1.3 | 44.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
1.3 | 14.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
1.3 | 20.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
1.2 | 15.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
1.1 | 9.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
1.1 | 18.0 | PID IL3 PATHWAY | IL3-mediated signaling events |
1.1 | 45.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
1.1 | 35.6 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
1.1 | 1.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
1.0 | 10.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
1.0 | 2.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.9 | 1.9 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.9 | 1.8 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.9 | 34.7 | PID PLK1 PATHWAY | PLK1 signaling events |
0.9 | 18.7 | PID MYC PATHWAY | C-MYC pathway |
0.8 | 20.4 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.8 | 1.7 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.8 | 7.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.8 | 0.8 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.8 | 21.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.8 | 7.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.8 | 19.5 | PID ATM PATHWAY | ATM pathway |
0.8 | 33.2 | PID P73PATHWAY | p73 transcription factor network |
0.8 | 19.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.8 | 12.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.7 | 28.5 | PID E2F PATHWAY | E2F transcription factor network |
0.7 | 17.2 | PID FOXO PATHWAY | FoxO family signaling |
0.7 | 22.3 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.7 | 17.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.7 | 9.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.7 | 6.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.7 | 17.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.7 | 11.0 | PID ARF 3PATHWAY | Arf1 pathway |
0.7 | 20.9 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.7 | 26.9 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.7 | 7.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.7 | 2.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.6 | 5.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.6 | 11.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.6 | 10.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.6 | 6.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.6 | 7.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.6 | 5.4 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.6 | 20.4 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.6 | 7.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.6 | 18.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.5 | 10.4 | PID P53 REGULATION PATHWAY | p53 pathway |
0.5 | 26.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.5 | 2.7 | PID IFNG PATHWAY | IFN-gamma pathway |
0.5 | 3.2 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.5 | 6.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.5 | 1.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.5 | 4.7 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.5 | 1.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.5 | 5.0 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.5 | 6.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.5 | 17.3 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.5 | 5.9 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.4 | 3.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.4 | 4.9 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.4 | 3.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.4 | 6.2 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.4 | 2.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.4 | 10.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.4 | 0.8 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.4 | 9.1 | PID BCR 5PATHWAY | BCR signaling pathway |
0.4 | 13.6 | PID NOTCH PATHWAY | Notch signaling pathway |
0.4 | 5.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.4 | 11.3 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.4 | 6.0 | PID ATR PATHWAY | ATR signaling pathway |
0.4 | 0.4 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.4 | 7.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.4 | 4.3 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.4 | 1.8 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.4 | 4.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.3 | 1.0 | PID IGF1 PATHWAY | IGF1 pathway |
0.3 | 6.3 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.3 | 3.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.3 | 8.6 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.3 | 0.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.3 | 2.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.3 | 0.9 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.3 | 0.9 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.3 | 6.7 | PID AURORA B PATHWAY | Aurora B signaling |
0.3 | 3.3 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.3 | 5.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.3 | 0.6 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.3 | 0.3 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.3 | 2.8 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.3 | 1.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.3 | 2.8 | PID BARD1 PATHWAY | BARD1 signaling events |
0.3 | 8.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.3 | 13.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.3 | 3.0 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 1.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 1.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 1.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 1.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 0.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 0.5 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 1.4 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.2 | 0.8 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 4.1 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.2 | 3.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 3.9 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 0.7 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 1.2 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 1.9 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 2.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 1.0 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 1.8 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 3.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 0.1 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.1 | 1.3 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 1.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 0.6 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 1.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 1.6 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 0.2 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.1 | 1.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 0.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 2.2 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 0.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 1.2 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 2.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.8 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 0.6 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.0 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 5.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 13.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
3.0 | 29.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
2.1 | 21.0 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
2.1 | 2.1 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
2.0 | 24.3 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
2.0 | 23.8 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.9 | 13.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
1.8 | 3.7 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
1.8 | 15.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
1.7 | 18.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
1.6 | 16.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
1.6 | 29.8 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
1.6 | 1.6 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
1.5 | 1.5 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
1.4 | 19.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
1.3 | 21.4 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
1.3 | 7.6 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
1.3 | 12.5 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
1.2 | 33.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
1.2 | 11.0 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
1.1 | 11.4 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
1.1 | 11.3 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
1.1 | 5.6 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
1.1 | 15.7 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
1.1 | 22.5 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
1.1 | 13.9 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
1.1 | 33.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
1.0 | 12.4 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
1.0 | 11.3 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
1.0 | 8.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
1.0 | 8.1 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
1.0 | 14.0 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
1.0 | 4.9 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
1.0 | 2.0 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
1.0 | 10.7 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
1.0 | 2.9 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
1.0 | 1.9 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
1.0 | 11.5 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
1.0 | 12.4 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
1.0 | 11.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
1.0 | 3.8 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.9 | 13.0 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.9 | 5.5 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.9 | 12.8 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.9 | 2.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.9 | 9.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.9 | 7.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.9 | 5.4 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.9 | 44.9 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.9 | 16.0 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.9 | 14.2 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.9 | 12.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.9 | 13.1 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.9 | 17.9 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.8 | 4.2 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.8 | 23.7 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.8 | 18.8 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.8 | 16.1 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.8 | 9.6 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.8 | 55.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.8 | 24.5 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.8 | 3.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.8 | 7.6 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.8 | 8.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.8 | 11.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.8 | 12.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.8 | 1.5 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.7 | 6.7 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.7 | 8.2 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.7 | 26.2 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.7 | 15.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.7 | 6.4 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.7 | 5.7 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.7 | 7.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.7 | 21.1 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.7 | 57.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.7 | 16.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.7 | 5.6 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.7 | 33.7 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.7 | 5.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.7 | 1.4 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.7 | 14.3 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.7 | 0.7 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.7 | 17.6 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.7 | 54.3 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.6 | 8.9 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.6 | 0.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.6 | 0.6 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.6 | 5.5 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.6 | 4.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.6 | 2.4 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.6 | 3.0 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.6 | 13.2 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.6 | 6.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.6 | 7.6 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.6 | 16.1 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.6 | 4.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.6 | 0.6 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.6 | 11.5 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.6 | 4.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.6 | 6.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.6 | 20.5 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.6 | 4.0 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.6 | 8.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.6 | 5.6 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.6 | 5.6 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.6 | 8.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.6 | 6.6 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.6 | 24.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.6 | 7.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.5 | 2.7 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.5 | 7.0 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.5 | 3.2 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.5 | 5.9 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.5 | 0.5 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.5 | 1.1 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.5 | 6.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.5 | 5.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.5 | 0.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.5 | 3.6 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.5 | 10.2 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.5 | 39.3 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.5 | 10.2 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.5 | 6.3 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.5 | 13.0 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.5 | 1.4 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.5 | 11.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.5 | 11.5 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.5 | 40.2 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.5 | 6.9 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.5 | 0.9 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.5 | 3.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.4 | 3.6 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.4 | 6.7 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.4 | 8.7 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.4 | 2.6 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.4 | 11.1 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.4 | 3.0 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.4 | 8.9 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.4 | 4.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.4 | 4.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.4 | 1.7 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.4 | 4.1 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.4 | 4.9 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.4 | 10.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.4 | 6.8 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.4 | 8.4 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.4 | 8.6 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.4 | 6.8 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.4 | 39.5 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.4 | 3.3 | REACTOME METABOLISM OF MRNA | Genes involved in Metabolism of mRNA |
0.4 | 0.7 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.4 | 2.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.4 | 3.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.4 | 0.7 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.3 | 3.8 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.3 | 0.7 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.3 | 8.2 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.3 | 1.7 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.3 | 0.3 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.3 | 5.7 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.3 | 1.6 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.3 | 1.3 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.3 | 4.9 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.3 | 5.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.3 | 1.2 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.3 | 10.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.3 | 10.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.3 | 8.2 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.3 | 1.7 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.3 | 0.6 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.3 | 1.1 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.3 | 1.0 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.3 | 6.2 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.3 | 1.3 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.3 | 3.8 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.2 | 0.7 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.2 | 1.7 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 1.2 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.2 | 1.7 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.2 | 1.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 0.7 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.2 | 1.6 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.2 | 0.2 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.2 | 24.3 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 2.5 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.2 | 0.6 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.2 | 1.6 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.2 | 1.4 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.2 | 0.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.2 | 2.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 1.1 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.2 | 4.9 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.2 | 1.6 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.2 | 3.0 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 0.7 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.2 | 1.3 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.2 | 0.7 | REACTOME ACTIVATED TLR4 SIGNALLING | Genes involved in Activated TLR4 signalling |
0.2 | 0.7 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.2 | 9.6 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.2 | 1.5 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.2 | 0.9 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 2.1 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.1 | 0.1 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 0.3 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 0.8 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 3.2 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 0.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.1 | 0.1 | REACTOME MITOTIC G1 G1 S PHASES | Genes involved in Mitotic G1-G1/S phases |
0.1 | 1.3 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 3.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 0.5 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.1 | 0.2 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.1 | 0.5 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 1.9 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.1 | 0.1 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.1 | 1.9 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.1 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |